<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<!-- saved from url=(0052)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/ -->
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="aac"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3195022/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Pharmacokinetics of Voriconazole Administered Concomitantly with Fluconazole and Population-Based Simulation for Sequential Use </title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="./PMC3195022_files/jig.min.css"><script type="text/javascript" src="./PMC3195022_files/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Antimicrobial Agents and Chemotherapy"><meta name="citation_title" content="Pharmacokinetics of Voriconazole Administered Concomitantly with Fluconazole and Population-Based Simulation for Sequential Use "><meta name="citation_authors" content="Bharat Damle, Manthena V. Varma, Nolan Wood"><meta name="citation_date" content="November 2011"><meta name="citation_issue" content="11"><meta name="citation_volume" content="55"><meta name="citation_firstpage" content="5172"><meta name="citation_doi" content="10.1128/AAC.00423-11"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3195022/?report=abstract"><meta name="citation_pmid" content="21876043"><meta name="DC.Title" content="Pharmacokinetics of Voriconazole Administered Concomitantly with Fluconazole and Population-Based Simulation for Sequential Use "><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="American Society for Microbiology (ASM)"><meta name="DC.Contributor" content="Bharat Damle"><meta name="DC.Contributor" content="Manthena V. Varma"><meta name="DC.Contributor" content="Nolan Wood"><meta name="DC.Date" content="2011 Nov"><meta name="DC.Identifier" content="10.1128/AAC.00423-11"><meta name="DC.Language" content="en"><meta property="og:title" content="Pharmacokinetics of Voriconazole Administered Concomitantly with Fluconazole and Population-Based Simulation for Sequential Use "><meta property="og:type" content="article"><meta property="og:description" content="In clinical practice, antifungal therapy may be switched from fluconazole to voriconazole; such sequential use poses the potential for drug interaction due to cytochrome P450 2C19 (CYP2C19)-mediated inhibition of voriconazole metabolism. This open-label, ..."><meta property="og:url" content="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="http://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="./PMC3195022_files/pmc.min.css" type="text/css"><link rel="stylesheet" href="./PMC3195022_files/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="./PMC3195022_files/common.min.js">//</script><script type="text/javascript" src="./PMC3195022_files/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:&#39;/pmc/utils/ctxp/&#39;"><script type="text/javascript" src="./PMC3195022_files/jquery.citationexporter.js">//</script><link rel="stylesheet" href="./PMC3195022_files/citationexporter.css" type="text/css"><script type="text/javascript" src="./PMC3195022_files/MathJax.js"></script><script type="text/javascript" src="./PMC3195022_files/large-obj-scrollbars.min.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-aac.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><link rel="alternate" type="application/epub+zip" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/epub/"><link rel="alternate" type="application/pdf" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/pdf/zac5172.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="http://www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="8A1A296D76C2A43100000000009536A0"><link type="text/css" rel="stylesheet" href="./PMC3195022_files/3855312.css"><link type="text/css" rel="stylesheet" href="./PMC3195022_files/3929378.css" media="print"><style type="text/css" media="print">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }.print-log li { list-style-image: url('http://www.ncbi.nlm.nih.gov/stat?jsevent=print&ncbi_app=pmc&ncbi_db=pmc&ncbi_pcid=%2Farticles%2FPMC3195022%2F&ncbi_pdid=article&ncbi_phid=8A1A296D76C2A43100000000009536A0'); }</style><style type="text/css">.print-log { position:absolute;left:-10000px;top:auto;width:1px;height:1px;overflow:hidden; }</style><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1em; bottom: 1.5em; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-jig-5"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	&lt;p class="nojs"&gt;
	&lt;strong&gt;Warning:&lt;/strong&gt;
	The NCBI web site requires JavaScript to function. 
	&lt;a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank"&gt;more...&lt;/a&gt;
	&lt;/p&gt;
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="http://www.ncbi.nlm.nih.gov/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="./PMC3195022_files/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="http://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a><ul id="resources-submenu" class="ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/all/" tabindex="-1" role="menuitem">All Resources</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#chemicals-bioassays" tabindex="-1" role="menuitem" class="expandRight">Chemicals &amp; Bioassays</a><ul class="actual-resources-submenu chemicals-bioassays ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pcassay" title=" Contributed bioactivity data for PubChem Substances " tabindex="-1" role="menuitem">PubChem BioAssay</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pccompound" title=" Unique, standardized chemical structures " tabindex="-1" role="menuitem">PubChem Compound</a></li><li role="presentation"><a href="https://pubchem.ncbi.nlm.nih.gov/search/search.cgi" title=" Searches PubChem Compound by chemical structure " tabindex="-1" role="menuitem">PubChem Structure Search</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pcsubstance" title=" Provides information on the biological activities of small molecules. " tabindex="-1" role="menuitem">PubChem Substance</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/chemicals-bioassays/" tabindex="-1" role="menuitem">All Chemicals &amp; Bioassays Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#dna-rna" tabindex="-1" role="menuitem" class="expandRight">DNA &amp; RNA</a><ul class="actual-resources-submenu dna-rna ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/" title=" DNA and RNA sequences submitted to NCBI " tabindex="-1" role="menuitem">GenBank</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/WebSub/?tool=genbank" title=" Web tool for simple submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: BankIt</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/Sequin/" title=" Software tool for complex submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: Sequin</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/tbl2asn2/" title=" Command-line program for submitting sequence data " tabindex="-1" role="menuitem">GenBank: tbl2asn</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/nuccore" title=" Nucleotide sequence data in GenBank and RefSeq " tabindex="-1" role="menuitem">Nucleotide Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/popset" title=" Sets of nucleotide sequences representing a population " tabindex="-1" role="menuitem">PopSet</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/primer-blast/" title=" Designs PCR primers and analyzes them for target specificity using BLAST. " tabindex="-1" role="menuitem">Primer-BLAST</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/" title=" Curated nucleotide and protein sequences produced by NCBI " tabindex="-1" role="menuitem">Reference Sequence (RefSeq)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/rsg/" title=" RefSeqGene reference standards for genomic sequences of well-characterized genes " tabindex="-1" role="menuitem">RefSeqGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?" title=" Database of sequences reads from next generation sequencing technologies " tabindex="-1" role="menuitem">Sequence Read Archive (SRA)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/trace.cgi" title=" DNA chromatograms, base calls, and quality estimates for single-pass reads. " tabindex="-1" role="menuitem">Trace Archive</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/unigene" title=" Gene-centered clusters of transcripts and ESTs " tabindex="-1" role="menuitem">UniGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/dna-rna/" tabindex="-1" role="menuitem">All DNA &amp; RNA Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#data-software" tabindex="-1" role="menuitem" class="expandRight">Data &amp; Software</a><ul class="actual-resources-submenu data-software ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml" title=" Program for viewing 3D structures and alignments " tabindex="-1" role="menuitem">Cn3D</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/WebSub/?tool=genbank" title=" Web tool for simple submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: BankIt</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/Sequin/" title=" Software tool for complex submissions of nucleotide sequences " tabindex="-1" role="menuitem">GenBank: Sequin</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/tbl2asn2/" title=" Command-line program for submitting sequence data " tabindex="-1" role="menuitem">GenBank: tbl2asn</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/primer-blast/" title=" Designs PCR primers and analyzes them for target specificity using BLAST. " tabindex="-1" role="menuitem">Primer-BLAST</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="https://pubchem.ncbi.nlm.nih.gov/search/search.cgi" title=" Searches PubChem Compound by chemical structure " tabindex="-1" role="menuitem">PubChem Structure Search</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/SNP/" title=" The SNP database tools page provides links to the general submission guidelines and to the submission handle request. " tabindex="-1" role="menuitem">SNP Submission Tool</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/VAST/vast.html" title=" Tool that generates 3D structural alignments " tabindex="-1" role="menuitem">Vector Alignment Search Tool (VAST)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/data-software/" tabindex="-1" role="menuitem">All Data &amp; Software Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#domains-structures" tabindex="-1" role="menuitem" class="expandRight">Domains &amp; Structures</a><ul class="actual-resources-submenu domains-structures ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml" title=" Program for viewing 3D structures and alignments " tabindex="-1" role="menuitem">Cn3D</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/cdd" title=" Database of conserved protein domains represented by multiple sequence alignments " tabindex="-1" role="menuitem">Conserved Domain Database (CDD)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/structure/" title=" Database of 3D macromolecular structures derived from PDB " tabindex="-1" role="menuitem">Structure (Molecular Modeling Database)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/VAST/vast.html" title=" Tool that generates 3D structural alignments " tabindex="-1" role="menuitem">Vector Alignment Search Tool (VAST)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/domains-structures/" tabindex="-1" role="menuitem">All Domains &amp; Structures Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#genes-expression" tabindex="-1" role="menuitem" class="expandRight">Genes &amp; Expression</a><ul class="actual-resources-submenu genes-expression ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gap" title=" Genotype/Phenotype association studies " tabindex="-1" role="menuitem">Database of Genotypes and Phenotypes (dbGaP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gene" title=" Database of gene loci and associated transcripts and proteins " tabindex="-1" role="menuitem">Gene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/geo/" title=" Gene Expression Omnibus (GEO) Database " tabindex="-1" role="menuitem">Gene Expression Omnibus (GEO) Database </a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gds" title=" Curated collections of gene expression data sets " tabindex="-1" role="menuitem">Gene Expression Omnibus (GEO) Datasets</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/geoprofiles/" title=" Database of gene expression Profiles for individual sequences " tabindex="-1" role="menuitem">Gene Expression Omnibus (GEO) Profiles</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/homologene" title=" Sets of homologous eukaryotic genes " tabindex="-1" role="menuitem">HomoloGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mapview/" title=" Tool for searching, viewing and downloading genomic maps and related data " tabindex="-1" role="menuitem">Map Viewer</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/omim" title=" Database of human genes and genetic disorders " tabindex="-1" role="menuitem">Online Mendelian Inheritance in Man (OMIM)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/rsg/" title=" RefSeqGene reference standards for genomic sequences of well-characterized genes " tabindex="-1" role="menuitem">RefSeqGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/unigene" title=" Gene-centered clusters of transcripts and ESTs " tabindex="-1" role="menuitem">UniGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genes-expression/" tabindex="-1" role="menuitem">All Genes &amp; Expression Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#genetics-medicine" tabindex="-1" role="menuitem" class="expandRight">Genetics &amp; Medicine</a><ul class="actual-resources-submenu genetics-medicine ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books" title=" Online biomedical books " tabindex="-1" role="menuitem">Bookshelf</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gap" title=" Genotype/Phenotype association studies " tabindex="-1" role="menuitem">Database of Genotypes and Phenotypes (dbGaP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gtr/" title=" Detailed information about genetic tests and labs " tabindex="-1" role="menuitem">Genetic Testing Registry</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mapview/" title=" Tool for searching, viewing and downloading genomic maps and related data " tabindex="-1" role="menuitem">Map Viewer</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/omim" title=" Database of human genes and genetic disorders " tabindex="-1" role="menuitem">Online Mendelian Inheritance in Man (OMIM)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed" title=" Biomedical literature abstracts " tabindex="-1" role="menuitem">PubMed</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/" title=" Free, full-text articles " tabindex="-1" role="menuitem">PubMed Central (PMC)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed/clinical" title=" Directory of PubMed queries about clinical topics " tabindex="-1" role="menuitem">PubMed Clinical Queries</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/rsg/" title=" RefSeqGene reference standards for genomic sequences of well-characterized genes " tabindex="-1" role="menuitem">RefSeqGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genetics-medicine/" tabindex="-1" role="menuitem">All Genetics &amp; Medicine Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#genomes-maps" tabindex="-1" role="menuitem" class="expandRight">Genomes &amp; Maps</a><ul class="actual-resources-submenu genomes-maps ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/dbvar" title=" A database of genomic structural variation " tabindex="-1" role="menuitem">Database of Genomic Structural Variation (dbVar)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genbank/tbl2asn2/" title=" Command-line program for submitting sequence data " tabindex="-1" role="menuitem">GenBank: tbl2asn</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sites/genome" title=" Curated genomic DNA sequences " tabindex="-1" role="menuitem">Genome</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/bioproject/" title=" Central status pages for genome sequencing projects " tabindex="-1" role="menuitem">Genome Project</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mapview/" title=" Tool for searching, viewing and downloading genomic maps and related data " tabindex="-1" role="menuitem">Map Viewer</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/nuccore" title=" Nucleotide sequence data in GenBank and RefSeq " tabindex="-1" role="menuitem">Nucleotide Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/popset" title=" Sets of nucleotide sequences representing a population " tabindex="-1" role="menuitem">PopSet</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?" title=" Database of sequences reads from next generation sequencing technologies " tabindex="-1" role="menuitem">Sequence Read Archive (SRA)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Traces/trace.cgi" title=" DNA chromatograms, base calls, and quality estimates for single-pass reads. " tabindex="-1" role="menuitem">Trace Archive</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genomes-maps/" tabindex="-1" role="menuitem">All Genomes &amp; Maps Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#homology" tabindex="-1" role="menuitem" class="expandRight">Homology</a><ul class="actual-resources-submenu homology ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/blink.cgi?mode=query" title=" Pre-computed reports showing proteins with similar sequences " tabindex="-1" role="menuitem">BLAST Link (BLink)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/cdd" title=" Database of conserved protein domains represented by multiple sequence alignments " tabindex="-1" role="menuitem">Conserved Domain Database (CDD)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/homologene" title=" Sets of homologous eukaryotic genes " tabindex="-1" role="menuitem">HomoloGene</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/proteinclusters" title=" Clusters of related proteins from prokaryotes and organelles " tabindex="-1" role="menuitem">Protein Clusters</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/homology/" tabindex="-1" role="menuitem">All Homology Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#literature" tabindex="-1" role="menuitem" class="expandRight">Literature</a><ul class="actual-resources-submenu literature ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books" title=" Online biomedical books " tabindex="-1" role="menuitem">Bookshelf</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/nlmcatalog/journals" title=" Information on journals cited by NCBI records " tabindex="-1" role="menuitem">Journals in NCBI Databases</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/mesh" title=" Controlled vocabulary for MEDLINE " tabindex="-1" role="menuitem">MeSH Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK143764/" title=" Introductory articles about NCBI resources " tabindex="-1" role="menuitem">NCBI Handbook</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK3831/" title=" Online, searchable help documentation " tabindex="-1" role="menuitem">NCBI Help Manual</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK1969/" title=" NCBI&#39;s monthly newsletter " tabindex="-1" role="menuitem">NCBI News</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed" title=" Biomedical literature abstracts " tabindex="-1" role="menuitem">PubMed</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/" title=" Free, full-text articles " tabindex="-1" role="menuitem">PubMed Central (PMC)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmed/clinical" title=" Directory of PubMed queries about clinical topics " tabindex="-1" role="menuitem">PubMed Clinical Queries</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pubmedhealth/" title=" Reviews of clinical effectiveness research " tabindex="-1" role="menuitem">PubMed Health</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/literature/" tabindex="-1" role="menuitem">All Literature Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#proteins" tabindex="-1" role="menuitem" class="expandRight">Proteins</a><ul class="actual-resources-submenu proteins ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/biosystems/" title=" Database that groups biomedical literature, small molecules, and sequence data in terms of biological relationships. " tabindex="-1" role="menuitem">BioSystems</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/blink.cgi?mode=query" title=" Pre-computed reports showing proteins with similar sequences " tabindex="-1" role="menuitem">BLAST Link (BLink)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/cdd" title=" Database of conserved protein domains represented by multiple sequence alignments " tabindex="-1" role="menuitem">Conserved Domain Database (CDD)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK25501/" title=" URL application programming interface for searching, linking and downloading data within NCBI&#39;s Entrez system " tabindex="-1" role="menuitem">E-Utilities</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/proteinclusters" title=" Clusters of related proteins from prokaryotes and organelles " tabindex="-1" role="menuitem">Protein Clusters</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/protein" title=" Protein sequence data " tabindex="-1" role="menuitem">Protein Database</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/refseq/" title=" Curated nucleotide and protein sequences produced by NCBI " tabindex="-1" role="menuitem">Reference Sequence (RefSeq)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/proteins/" tabindex="-1" role="menuitem">All Proteins Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#sequence-analysis" tabindex="-1" role="menuitem" class="expandRight">Sequence Analysis</a><ul class="actual-resources-submenu sequence-analysis ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" title=" Tool for finding local regions of sequence similarity " tabindex="-1" role="menuitem">BLAST (Basic Local Alignment Search Tool)</a></li><li role="presentation"><a href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?CMD=Web&amp;PAGE_TYPE=BlastDocs&amp;DOC_TYPE=Download" title=" BLAST programs for a local computer " tabindex="-1" role="menuitem">BLAST (Stand-alone)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/blink.cgi?mode=query" title=" Pre-computed reports showing proteins with similar sequences " tabindex="-1" role="menuitem">BLAST Link (BLink)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi" title=" Locates conserved domains within a protein sequence " tabindex="-1" role="menuitem">Conserved Domain Search Service (CD Search)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/protmap.cgi" title=" Maps proteins from a COG/VOG back to its genome " tabindex="-1" role="menuitem">Genome ProtMap</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/gbench/" title=" Stand-alone application for analyzing sequence data " tabindex="-1" role="menuitem">Genome Workbench</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/genomes/FLU/" title=" Data from the NIAID Influenza Genome Sequencing Project " tabindex="-1" role="menuitem">Influenza Virus</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/tools/primer-blast/" title=" Designs PCR primers and analyzes them for target specificity using BLAST. " tabindex="-1" role="menuitem">Primer-BLAST</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/static/prosplign/prosplign.html" title=" Tool for aligning proteins to genomic DNA " tabindex="-1" role="menuitem">ProSplign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/sutils/splign/" title=" Tool for aligning transcripts to genomic DNA " tabindex="-1" role="menuitem">Splign</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/sequence-analysis/" tabindex="-1" role="menuitem">All Sequence Analysis Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#taxonomy" tabindex="-1" role="menuitem" class="expandRight">Taxonomy</a><ul class="actual-resources-submenu taxonomy ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/taxonomy" title=" The NCBI taxonomy tree in Entrez " tabindex="-1" role="menuitem">Taxonomy</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Root" title=" Displays and links Entrez data to each taxonomic node " tabindex="-1" role="menuitem">Taxonomy Browser</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/Taxonomy/CommonTree/wwwcmt.cgi" title=" Creates custom taxonomic trees " tabindex="-1" role="menuitem">Taxonomy Common Tree</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/taxonomy/" tabindex="-1" role="menuitem">All Taxonomy Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#training-tutorials" tabindex="-1" role="menuitem" class="expandRight">Training &amp; Tutorials</a><ul class="actual-resources-submenu training-tutorials ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/education/" title=" Central page providing links to tutorials and training materials " tabindex="-1" role="menuitem">NCBI Education Page</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK143764/" title=" Introductory articles about NCBI resources " tabindex="-1" role="menuitem">NCBI Handbook</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK3831/" title=" Online, searchable help documentation " tabindex="-1" role="menuitem">NCBI Help Manual</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/books/NBK1969/" title=" NCBI&#39;s monthly newsletter " tabindex="-1" role="menuitem">NCBI News</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/training-tutorials/" tabindex="-1" role="menuitem">All Training &amp; Tutorials Resources...</a></li></ul></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#variation" tabindex="-1" role="menuitem" class="expandRight">Variation</a><ul class="actual-resources-submenu variation ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/dbvar" title=" A database of genomic structural variation " tabindex="-1" role="menuitem">Database of Genomic Structural Variation (dbVar)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/gap" title=" Genotype/Phenotype association studies " tabindex="-1" role="menuitem">Database of Genotypes and Phenotypes (dbGaP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/snp" title=" Database of nucleotide sequence polymorphisms " tabindex="-1" role="menuitem">Database of Single Nucleotide Polymorphisms (dbSNP)</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/projects/SNP/" title=" The SNP database tools page provides links to the general submission guidelines and to the submission handle request. " tabindex="-1" role="menuitem">SNP Submission Tool</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/variation/" tabindex="-1" role="menuitem">All Variation Resources...</a></li></ul></li></ul></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="http://www.ncbi.nlm.nih.gov/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a><ul id="howto-submenu" class="ui-ncbibasicmenu" role="menu"><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/all/#howtos" tabindex="-1" role="menuitem">All How To</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/chemicals-bioassays/#howtos" tabindex="-1" role="menuitem">Chemicals &amp; Bioassays</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/dna-rna/#howtos" tabindex="-1" role="menuitem">DNA &amp; RNA</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/data-software/#howtos" tabindex="-1" role="menuitem">Data &amp; Software</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/domains-structures/#howtos" tabindex="-1" role="menuitem">Domains &amp; Structures</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genes-expression/#howtos" tabindex="-1" role="menuitem">Genes &amp; Expression</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genetics-medicine/#howtos" tabindex="-1" role="menuitem">Genetics &amp; Medicine</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/genomes-maps/#howtos" tabindex="-1" role="menuitem">Genomes &amp; Maps</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/homology/#howtos" tabindex="-1" role="menuitem">Homology</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/literature/#howtos" tabindex="-1" role="menuitem">Literature</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/proteins/#howtos" tabindex="-1" role="menuitem">Proteins</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/sequence-analysis/#howtos" tabindex="-1" role="menuitem">Sequence Analysis</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/taxonomy/#howtos" tabindex="-1" role="menuitem">Taxonomy</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/training-tutorials/#howtos" tabindex="-1" role="menuitem">Training &amp; Tutorials</a></li><li role="presentation"><a href="http://www.ncbi.nlm.nih.gov/guide/variation/#howtos" tabindex="-1" role="menuitem">Variation</a></li></ul></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="http://www.ncbi.nlm.nih.gov/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="http://www.ncbi.nlm.nih.gov/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="http://www.ncbi.nlm.nih.gov/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="http://www.ncbi.nlm.nih.gov/account/?back_url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3195022%2F" id="sign_in">Sign in to NCBI</a><a href="http://www.ncbi.nlm.nih.gov/account/signout/?back_url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3195022%2F" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="http://www.ncbi.nlm.nih.gov/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="http://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="http://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="http://www.ncbi.nlm.nih.gov/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="pubmed" class="last">PubMed</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="clone">Clone</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="nucest">EST</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="nucgss">GSS</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="pubmedhealth">PubMed Health</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbook">ToolKitBook</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="ui-ncbiclearbutton-wrap box-shadow"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" config="dictionary:&#39;pmc-search-autocomplete&#39;,disableUrl:&#39;NcbiSearchBarAutoComplCtrl&#39;" autocomplete="off" data-sbconfig="ds:&#39;no&#39;,pjs:&#39;no&#39;,afs:&#39;yes&#39;" aria-haspopup="true" aria-autocomplete="list" role="textbox"><a class="reset" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" style="visibility: hidden;"><img src="./PMC3195022_files/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/limits/">Limits</a>
                    </li><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="http://www.ncbi.nlm.nih.gov/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="http://www.ncbi.nlm.nih.gov/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="http://www.ncbi.nlm.nih.gov/pmc/journals/" class="navlink">Journal List</a></li><li class="archive-page"><a class="navlink" href="http://www.ncbi.nlm.nih.gov/pmc/journals/82/">Antimicrob Agents Chemother</a></li><li class="issue-page"><a class="navlink" href="http://www.ncbi.nlm.nih.gov/pmc/issues/201205/">v.55(11); 2011 Nov</a></li><li class="accid">PMC3195022</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="./PMC3195022_files/logo-aac.gif" alt="Logo of aac" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="321,60,397,75" alt="Permissions" title="Permissions" href="http://journals.asm.org/misc/reprints.dtl" ref="reftype=publisher&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"><area shape="rect" coords="398,60,500,75" alt="Journals.ASM.org" title="Journals.ASM.org" href="http://journals.asm.org/" ref="reftype=publisher&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"><area shape="rect" coords="0,0,500,55" alt="Journal" title="Journal" href="http://aac.asm.org/" ref="reftype=publisher&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"><area shape="rect" coords="48,60,118,75" alt="AAC Article" title="AAC Article" href="http://aac.asm.org/cgi/content/full/55/11/5172" ref="reftype=publisher&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CBanner&amp;TO=Publisher%7CArticle%7CFullText&amp;rendering-type=normal" target="pmc_ext"><area shape="rect" coords="119,60,195,75" alt="Journal Info" title="Journal Info" href="http://aac.asm.org/misc/about.dtl" ref="reftype=publisher&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"><area shape="rect" coords="195,60,251,75" alt="Authors" title="Authors" href="http://aac.asm.org/misc/authors.dtl" ref="reftype=publisher&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"><area shape="rect" coords="252,60,318,75" alt="Reviewers" title="Reviewers" href="http://aac.asm.org/misc/reviewers.dtl" ref="reftype=publisher&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [&#39;h2&#39;], headingExclude: &#39;:hidden&#39;" id="ui-jig-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="small"><div class="inline_block eight_col va_top"><div><div><span class="cit">Antimicrob Agents Chemother. 2011 Nov; 55(11): 5172–5177. </span></div><div>  <span class="doi">doi:&nbsp; <a href="http://dx.doi.org/10.1128%2FAAC.00423-11" target="pmc_ext" ref="reftype=other&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">10.1128/AAC.00423-11</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3195022</span></div></div></div></div></div><h1 class="content-title">Pharmacokinetics of Voriconazole Administered Concomitantly with Fluconazole and Population-Based Simulation for Sequential Use <sup><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#FN2" rid="FN2" class=" fn">▿</a></sup></h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Damle%20B%5Bauth%5D">Bharat Damle</a>,<sup>1,</sup><sup>*</sup> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Varma%20MV%5Bauth%5D">Manthena V. Varma</a>,<sup>2</sup> and  <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Wood%20N%5Bauth%5D">Nolan Wood</a><sup>3,</sup><sup>†</sup></div></div><div class="fm-panel small half_rhythm"><div class="fm-authors-info fm-panel hide half_rhythm" id="id223512_ai" style="display:none"><div class="fm-affl" lang="en"><sup>1</sup>Pfizer Inc., New York, New York</div><div class="fm-affl" lang="en"><sup>2</sup>Pfizer Inc., Groton, Connecticut</div><div class="fm-affl" lang="en"><sup>3</sup>Pfizer Ltd., Sandwich, United Kingdom</div><div id="cor1"><sup>*</sup>Corresponding author. Mailing address: Clinical Pharmacology, Pfizer Global Research and Development, 235 East 42nd Street, New York, NY 10017. Phone: (212) 733-4739. Fax: (646) 441-4493. E-mail: <a href="mailto:dev@null" data-email="moc.rezifp@elmad.tarahb" class="oemail">moc.rezifp@elmad.tarahb</a>.</div><div id="FN1"><sup>†</sup>Present address: Takeda Global Research and Development Centre (Europe) Ltd., London, United Kingdom.</div></div><div class="togglers"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" class="pmctoggle" rid="id223512_ai">Author information <span>►</span></a> <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" class="pmctoggle" rid="id223512_an">Article notes <span>►</span></a> <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" class="pmctoggle" rid="id223512_cpl">Copyright and License information <span>►</span></a></div><div class="fm-article-notes fm-panel hide half_rhythm" id="id223512_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2011 Mar 31; Revisions requested 2011 Jun 18; Accepted 2011 Aug 15.</div></div><div class="fm-cpl-info fm-panel hide half_rhythm" id="id223512_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="http://www.ncbi.nlm.nih.gov/pmc/about/copyright.html">Copyright</a>  © 2011, American Society for Microbiology. All Rights Reserved.</div></div></div><div class="links-box fm-panel whole_rhythm"><div class="small"><div>This article has been <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="__abstractid794491" lang="en" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-7"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true" id="ui-jig-8">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__abstractid794491title" style="text-transform: uppercase;">Abstract</h2><!--article-meta--><div><p id="__p2" class="p p-first-last">In clinical practice, antifungal therapy may be switched from fluconazole to voriconazole; such sequential use poses the potential for drug interaction due to cytochrome P450 2C19 (CYP2C19)-mediated inhibition of voriconazole metabolism. This open-label, randomized, two-way crossover study investigated the effect of concomitant fluconazole on voriconazole pharmacokinetics in 10 subjects: 8 extensive metabolizers and 2 poor metabolizers of CYP2C19. The study consisted of 4-day voriconazole-only and 5-day voriconazole-plus-fluconazole treatments, separated by a 14-day washout. Voriconazole pharmacokinetics were determined by noncompartmental analyses. A physiologically based pharmacokinetic model was developed in Simcyp (Simcyp Ltd., Sheffield, United Kingdom) to predict the magnitude of drug interaction should antifungal therapy be switched from fluconazole to voriconazole, following various simulated lag times for the switch. In CYP2C19 extensive metabolizers, fluconazole increased the maximum plasma concentration and the area under the plasma concentration-time curve (AUC) of voriconazole by 57% and 178%, respectively. In poor metabolizers, however, voriconazole pharmacokinetics were unaffected by fluconazole. The simulations based on pharmacokinetic modeling predicted that if voriconazole was started 6, 12, 24, or 36 h after the last dose of fluconazole, the voriconazole AUC ratios (sequential therapy versus voriconazole only) after the first dose would be 1.51, 1.41, 1.28, and 1.14, respectively. This suggests that the remaining systemic fluconazole would result in a marked drug interaction with voriconazole for ≥24 h. Although no safety issues were observed during coadministration, concomitant use of fluconazole and voriconazole is not recommended. Frequent monitoring for voriconazole-related adverse events is advisable if voriconazole is used sequentially after fluconazole.</p></div></div><div id="__sec1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-9"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-10">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec1title" style="text-transform: uppercase;">INTRODUCTION</h2><p id="__p3" class="p p-first">The pharmacokinetics of the triazole antifungal voriconazole have been widely studied (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121456" role="button" aria-expanded="false" aria-haspopup="true">7</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121478" role="button" aria-expanded="false" aria-haspopup="true">19</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121462" role="button" aria-expanded="false" aria-haspopup="true">20</a>). The drug is primarily metabolized by hepatic cytochrome P450 (CYP) enzymes 2C19 (CYP2C19) and CYP3A4, with <em>in vitro</em> data indicating only minimal involvement of CYP2C9 in its metabolism (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121441" role="button" aria-expanded="false" aria-haspopup="true">3</a>). Genetic polymorphism in CYP2C19 probably accounts for a substantial part of the intersubject variability in voriconazole pharmacokinetics (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121450" role="button" aria-expanded="false" aria-haspopup="true">22</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B29" rid="B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121448" role="button" aria-expanded="false" aria-haspopup="true">29</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121465" role="button" aria-expanded="false" aria-haspopup="true">30</a>). Voriconazole metabolism may also be influenced by the concomitant administration of other drugs interacting with CYP isozymes (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121442" role="button" aria-expanded="false" aria-haspopup="true">11</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121437" role="button" aria-expanded="false" aria-haspopup="true">25</a>), including the structurally related antifungal agent fluconazole (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121469" role="button" aria-expanded="false" aria-haspopup="true">12</a>).</p><p id="__p4">Voriconazole and fluconazole have similar mechanisms of action, and use of the combination of both drugs does not appear to offer an advantage over use of the single agents (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121445" role="button" aria-expanded="false" aria-haspopup="true">23</a>); therefore, it is unlikely that they would be administered together as combination therapy. However, voriconazole may be used sequentially after fluconazole in clinical practice. This situation is most likely to arise in hematology patients who are receiving fluconazole prophylaxis for the prevention of invasive <em>Candida</em> infections and who subsequently develop invasive aspergillosis, for which voriconazole is regarded the treatment of choice (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B18" rid="B18" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">18</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121453" role="button" aria-expanded="false" aria-haspopup="true">26</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121452" role="button" aria-expanded="false" aria-haspopup="true">28</a>). To a lesser extent, it may also occur in patients who are treated for invasive <em>Candida</em> infections later confirmed to be caused by fluconazole-resistant strains. The rationale for a therapeutic switch from fluconazole to voriconazole is supported by <em>in vitro</em> and <em>in vivo</em> data showing good activity of voriconazole against many fluconazole-resistant <em>Candida</em> strains, even though there is some azole cross-resistance (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B14" rid="B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121460" role="button" aria-expanded="false" aria-haspopup="true">14</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121477" role="button" aria-expanded="false" aria-haspopup="true">15</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121436" role="button" aria-expanded="false" aria-haspopup="true">21</a>). In Europe, voriconazole is specifically approved for the treatment of fluconazole-resistant, serious invasive <em>Candida</em> infections (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B2" rid="B2" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">2</a>).</p><p id="__p5">Fluconazole is a potent CYP2C19 inhibitor (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121464" role="button" aria-expanded="false" aria-haspopup="true">27</a>), and its systemic presence could inhibit voriconazole metabolism and potentially increase the frequency of voriconazole-related adverse events. In the treatment of serious and life-threatening fungal infections requiring a switch from fluconazole to voriconazole, it may not be feasible to delay voriconazole therapy to allow sufficient time for fluconazole washout. The elimination half-life of fluconazole is approximately 30 h in adults (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B16" rid="B16" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">16</a>), and fluconazole levels with the potential for inhibiting CYP2C19 activity may therefore be expected for some period of time following fluconazole discontinuation.</p><p id="__p6" class="p p-last">To examine these issues, we studied the pharmacokinetics of voriconazole when coadministered with fluconazole to assess the maximal impact of fluconazole-mediated CYP2C19 inhibition on voriconazole levels. A physiologically based pharmacokinetic (PBPK) modeling approach was then employed to predict the extent/magnitude of the drug interaction in situations where voriconazole therapy is initiated after various lag times following fluconazole discontinuation.</p></div><div id="__sec2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-11"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-12">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec2title" style="text-transform: uppercase;">MATERIALS AND METHODS</h2><div id="__sec3" class="sec sec-first"><p></p><h3 class="inline">Study design. </h3><p id="__p7" class="p p-first">This was an open-label, randomized, two-way crossover study involving 10 healthy volunteers conducted in Singapore. Subjects were included if they were male, were aged 21 to 55 years, had a body mass index of 18 to 30 kg/m<sup>2</sup>, and had a normal resting 12-lead electrocardiogram. Subjects were excluded if they had any clinically significant disease, allergy, or abnormality; were taking or had taken any prescribed or over-the-counter medication (except acetaminophen) within 3 weeks of starting the study; had received any experimental drug within 4 months of starting the study; had evidence of drug abuse or excessive use of alcohol or tobacco; had donated blood within the previous 8 weeks; had positive human immunodeficiency virus, hepatitis B virus, or hepatitis C virus serology; or had known hypersensitivity to azoles. All subjects gave their written informed consent prior to their participation.</p><p id="__p8">The study was divided into two treatments, a 4-day period of voriconazole-only treatment and a 5-day period of voriconazole-plus-fluconazole combination treatment, separated by a 14-day washout phase. The order in which subjects underwent these two treatments was assigned randomly. All treatments were administered orally in a fasted state. Voriconazole was given as a loading dose of 400 mg orally twice daily (every 12 h) on day 1, followed by 200 mg every 12 h on days 2 and 3 and a single 200-mg dose on day 4. Fluconazole was administered as a single loading dose of 400 mg orally on day 1, followed by single doses of 200 mg every 24 h on days 2 to 5. Water (240 ml) was used for the administration of both agents. During the combination treatment phase, fluconazole was administered immediately after the voriconazole dose.</p><p id="__p9" class="p p-last">A blood sample was taken at the screening visit to determine the CYP2C19 genotype status of each subject using previously validated methods (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B33" rid="B33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121463" role="button" aria-expanded="false" aria-haspopup="true">33</a>); the testing was conducted by Genaissance Pharmaceuticals, Morrisville, NC. All adverse events and their likely relationship to treatment were recorded throughout the study period. Physical examination, laboratory safety tests, vital signs, and 12-lead electrocardiogram measurements were used to evaluate safety.</p></div><div id="__sec4" class="sec"><p></p><h3 class="inline">Voriconazole pharmacokinetics. </h3><p id="__p10" class="p p-first">Serial plasma samples for voriconazole pharmacokinetics were collected predosing and at 1, 2, 3, 4, 6, 8, 10, 12, 16, 24, 36, and 48 h after dosing on day 4. Plasma samples were assayed for voriconazole by a previously validated method using automated solid-phase extraction, followed by liquid chromatographic tandem mass spectrometric analysis (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_326081465" role="button" aria-expanded="false" aria-haspopup="true">1</a>). The lower and upper limits of quantification were 10 and 3,000 ng/ml, respectively.</p><p id="__p11" class="p p-last">Voriconazole pharmacokinetic parameters were determined by noncompartmental analyses. Maximum observed plasma concentration (<em>C</em><sub>max</sub>), time to first occurrence of <em>C</em><sub>max</sub> (<em>T</em><sub>max</sub>), area under the plasma concentration-time curve between 0 and 12 h (AUC<sub>12</sub>), area under the plasma concentration-time curve from time zero to the time of the last measurable concentration (AUC<sub><em>t</em></sub>), and area under the curve to infinity (AUC<sub>inf</sub>) were determined on day 4 of each treatment period. <em>C</em><sub>max</sub> and <em>T</em><sub>max</sub> were obtained directly from recorded data, and AUC<sub>12</sub> and AUC<sub><em>t</em></sub> were calculated using the linear trapezoidal rule. AUC<sub>inf</sub> was calculated using the equation AUC<sub><em>t</em></sub> + (<em>C<sub>t</sub></em>*/<em>k</em><sub>el</sub>), where <em>C<sub>t</sub></em>* was the last measurable concentration and <em>k</em><sub>el</sub> was the apparent terminal-elimination-phase rate constant. All pharmacokinetic parameter values were calculated using WinNonlin Professional (version 3.2) software (Pharsight, Sunnyvale, CA).</p></div><div id="__sec5" class="sec"><p></p><h3 class="inline">Statistical analyses. </h3><p id="__p12" class="p p-first-last">Pharmacokinetic parameters for voriconazole calculated on day 4 of each treatment period were used as endpoints for the statistical analysis. AUC<sub>inf</sub>, AUC<sub><em>t</em></sub>, AUC<sub>12</sub>, and <em>C</em><sub>max</sub> were subjected to analysis of variance appropriate for the two-period, two-treatment crossover design. <em>T</em><sub>max</sub> was summarized descriptively. Parameters were calculated as mean values with 90% confidence intervals (CIs), ranges, and coefficients of variation (CVs). Each parameter was calculated separately for subjects found to be extensive metabolizers (EMs) or poor metabolizers (PMs) of voriconazole and was compared between voriconazole alone and the voriconazole-plus-fluconazole combination. All statistical analyses were performed using SAS (version 8.02) software (SAS Institute Inc., Cary, NC).</p></div><div id="__sec6" class="sec sec-last"><p></p><h3 class="inline">Pharmacokinetic (Simcyp) modeling and simulations. </h3><p id="__p13" class="p p-first">PBPK modeling and simulations of drug interaction were performed using Simcyp (Simcyp population-based absorption, distribution, metabolism, and elimination [ADME] simulator, version 9.03; Simcyp Ltd., Sheffield, United Kingdom). A Simcyp model for voriconazole was developed using the physicochemical properties, <em>in vitro</em> data, and clinical pharmacokinetic parameters obtained mainly from the in-house database (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/table/T1/" target="true" class="fig-table-link table figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span>Table 1</span></a>). The recombinant enzyme kinetics inputs (maximum reaction velocity [<em>V</em><sub>max</sub>] and Michaelis-Menten constant [<em>K<sub>m</sub></em>]) were means of the values from multiple sources that included in-house data (Pfizer, data on file) and data from published literature (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121447" role="button" aria-expanded="false" aria-haspopup="true">3</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121438" role="button" aria-expanded="false" aria-haspopup="true">9</a>).</p><!--table ft1--><!--table-wrap mode=article t1--><div class="table-wrap iconblock ten_col whole_rhythm clearfix" id="T1"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/table/T1/" target="table" rid-ob="ob-T1" rid-figpopup="T1" class="table img_link icnblk_img figpopup"><img alt="Table 1." title="Table 1." class="small-thumb" src="./PMC3195022_files/saved_resource" src-large="/pmc/articles/PMC3195022/table/T1/?report=previmg"></a><div class="icnblk_cntnt"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/table/T1/" target="table" rid-figpopup="T1" rid-ob="ob-T1">Table 1.</a></div><!--caption a4--><div><span>Summary of input parameters for voriconazole used in the Simcyp model</span></div></div></div><p id="__p17">For fluconazole, standard inputs available within Simcyp were utilized. The inhibition constant (<em>K<sub>i</sub></em>) of fluconazole for the CYP2C19 enzyme used for simulating drug-drug interaction was 2.1 μM (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121458" role="button" aria-expanded="false" aria-haspopup="true">31</a>). The literature reports <em>K<sub>i</sub></em> values for fluconazole-mediated CYP3A4 inhibition ranging from 1.9 to 63 μM; therefore, a mean value of 25.2 μM was used as the input for Simcyp modeling (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121470" role="button" aria-expanded="false" aria-haspopup="true">4</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121439" role="button" aria-expanded="false" aria-haspopup="true">8</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121471" role="button" aria-expanded="false" aria-haspopup="true">10</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121467" role="button" aria-expanded="false" aria-haspopup="true">31</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B34" rid="B34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121473" role="button" aria-expanded="false" aria-haspopup="true">34</a>).</p><p id="__p18" class="p p-last">Each simulation was performed for 100 subjects (10 trials × 10 subjects). The virtual population had a body weight of 70 kg, with ages ranging from 18 to 65 years, and included both sexes. The dose, dosing interval, and dosing duration of voriconazole and fluconazole in the simulation were identical to those used in the clinical study. Accordingly, voriconazole alone was dosed every 12 h for 4 days (first two doses of 400 mg and subsequent five doses of 200 mg each), or voriconazole was coadministered with fluconazole (first fluconazole dose of 400 mg and subsequent doses of 200 mg each every 24 h). For simulating sequential dosing, fluconazole dosing remained the same, while voriconazole administration was initiated at times of 6, 12, and 24 h following the last dose of fluconazole.</p></div></div><div id="__sec7" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-13"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-14">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec7title" style="text-transform: uppercase;">RESULTS</h2><div id="__sec8" class="sec sec-first"><p></p><h3 class="inline">Study population. </h3><p id="__p19" class="p p-first-last">Five subjects (mean age, 29 years; age range, 24 to 43 years) received voriconazole alone followed by voriconazole plus fluconazole, and five (mean age, 24 years; age range, 22 to 27 years) received voriconazole plus fluconazole followed by voriconazole alone. The mean weights in the two groups were 70 kg (range, 63 to 77 kg) and 65 kg (range, 56 to 77 kg), respectively, and the mean heights were 174 cm (range, 170 to 178 cm) and 170 cm (range 161 to 177 cm), respectively. All subjects were Asian and male. Eight subjects were EMs, and two were PMs (four EMs and one PM in each treatment group).</p></div><div id="__sec9" class="sec"><p></p><h3 class="inline">Pharmacokinetic data. </h3><p id="__p20" class="p p-first"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/figure/F1/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Figure 1</span></a> shows the mean plasma voriconazole concentration-time profile by metabolizer type and by treatment group. As expected, voriconazole concentrations in PMs were markedly higher than those in EMs. The <em>C</em><sub>max</sub> and AUC<sub>12</sub> of voriconazole in PMs were approximately 2.7- and 2.5-fold higher, respectively, than those in EMs (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/table/T2/" target="true" class="fig-table-link table figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a class="icnblk_img figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><img src="./PMC3195022_files/zac9991003190001.gif" class="small-thumb" alt="Fig. 1." title="Fig. 1." src-large="/pmc/articles/PMC3195022/bin/zac9991003190001.jpg"></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Fig. 1.</a></div><!--caption a4--><div><span>Mean plasma concentrations of voriconazole over time in extensive and poor metabolizers given voriconazole alone and voriconazole with concomitant fluconazole.</span></div></div></div><!--table ft1--><!--table-wrap mode=article t1--><div class="table-wrap iconblock ten_col whole_rhythm clearfix" id="T2"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/table/T2/" target="table" rid-ob="ob-T2" rid-figpopup="T2" class="table img_link icnblk_img figpopup"><img alt="Table 2." title="Table 2." class="small-thumb" src="./PMC3195022_files/saved_resource(1)" src-large="/pmc/articles/PMC3195022/table/T2/?report=previmg"></a><div class="icnblk_cntnt"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/table/T2/" target="table" rid-figpopup="T2" rid-ob="ob-T2">Table 2.</a></div><!--caption a4--><div><span>Pharmacokinetic parameters for voriconazole</span></div></div></div><p id="__p27">Coadministration of fluconazole had a different effect on voriconazole pharmacokinetics in EMs and PMs. In EMs, plasma concentrations of voriconazole were increased when coadministered with fluconazole compared with voriconazole alone, while in PMs, the concentration-time profiles were similar during both treatments (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/figure/F1/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span>Fig. 1</span></a>). In EMs, <em>C</em><sub>max</sub> and AUC<sub>12</sub> values increased significantly when fluconazole was coadministered with voriconazole compared with when voriconazole was administered alone (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/table/T2/" target="true" class="fig-table-link table figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). In PMs, the pharmacokinetic parameters were similar with the two treatments (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/table/T2/" target="true" class="fig-table-link table figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>).</p><p id="__p28" class="p p-last">Coadministration of fluconazole reduced the intersubject variability of voriconazole <em>C</em><sub>max</sub>s and AUCs in EMs (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/table/T2/" target="true" class="fig-table-link table figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>). In this group, the coefficient of variations in voriconazole pharmacokinetic parameters ranged from 18.7 to 34.9% for voriconazole plus fluconazole, whereas they ranged from 37.8 to 62.0% for voriconazole alone.</p></div><div id="__sec10" class="sec"><p></p><h3 class="inline">Simcyp modeling and simulations. </h3><p id="__p29" class="p p-first">The <em>in vitro</em> data and clinical pharmacokinetic parameters were used to build a PBPK model for voriconazole using Simcyp. <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/figure/F2/" target="figure" class="fig-table-link fig figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span>Figure 2</span></a> shows the predicted plasma concentrations for voriconazole in EMs and PMs using a dosing regimen identical to that used in the clinical study. For EMs, these simulations predicted ratios (voriconazole plus fluconazole versus fluconazole alone) of 2.65 (95% CI, 1.33 to 5.85) and 1.40 (95% CI, 1.14 to 2.20) for voriconazole AUC<sub><em>t</em></sub> and <em>C</em><sub>max</sub>, respectively. However, no significant effect was found in PMs. These results are in agreement with those observed in the clinical study (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/table/T2/" target="true" class="fig-table-link table figpopup" rid-figpopup="T2" rid-ob="ob-T2" co-legend-rid=""><span>Table 2</span></a>) and confirm the validity of the model.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock ten_col whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a class="icnblk_img figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><img src="./PMC3195022_files/zac9991003190002.gif" class="small-thumb" alt="Fig. 2." title="Fig. 2." src-large="/pmc/articles/PMC3195022/bin/zac9991003190002.jpg"></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Fig. 2.</a></div><!--caption a4--><div><span>Simulated mean plasma concentrations of voriconazole dosed alone or with concomitant fluconazole in extensive metabolizers (A) and poor metabolizers (B). Data points represent mean ± SD (<em>n</em> = 8) concentrations for extensive metabolizers and individual</span> <strong>...</strong></div></div></div><p id="__p31" class="p">Further simulations were carried out to evaluate the effect of sequential dosing of voriconazole following termination of fluconazole therapy. The doses of both drugs remained the same as in the clinical study, with the exception that voriconazole was initiated sequentially at various time intervals (6, 12, 24, and 36 h) after the last dose of fluconazole. Accordingly, fluconazole was given at a dose of 400 mg on day 1, followed by 200 mg every 24 h on days 2 to 5, and voriconazole was initiated sequentially at doses of 400 mg every 12 h on day 5, followed by 200 mg every 12 h on subsequent days. The pharmacokinetic parameters of interest from these simulations were the <em>C</em><sub>max</sub> and AUC values for voriconazole after the first loading dose of 400 mg, since this represents double the maintenance dose of 200 mg and could result in higher voriconazole concentrations due to fluconazole-mediated interaction. The predicted <em>C</em><sub>max</sub> and AUC values for voriconazole and their ratios (voriconazole after fluconazole versus voriconazole alone) are presented in <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/table/T3/" target="true" class="fig-table-link table figpopup" rid-figpopup="T3" rid-ob="ob-T3" co-legend-rid=""><span>Table 3</span></a>. The predicted <em>C</em><sub>max</sub>s were comparable for both treatments; however, the predicted AUC values for voriconazole were higher when this antifungal was given sequentially after fluconazole than when voriconazole was given alone. For instance, the voriconazole AUC ratio was 1.51 when voriconazole was started 6 h after the last dose of fluconazole, indicating a significant drug interaction. This effect diminished as the lag time for sequential dosing was increased, and at 12 and 24 h, the AUC ratios were 1.41 and 1.28, respectively. Furthermore, the mean effect was reduced to less than 20% (AUC ratio, 1.14) when the lag time for sequential dosing was increased to 36 h. Overall, the simulation results suggest that the inhibitory effect of fluconazole on voriconazole metabolism would last for at least 24 h after the last dose of fluconazole.</p><!--table ft1--><!--table-wrap mode=article t1--><div class="table-wrap iconblock ten_col whole_rhythm clearfix" id="T3"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/table/T3/" target="table" rid-ob="ob-T3" rid-figpopup="T3" class="table img_link icnblk_img figpopup"><img alt="Table 3." title="Table 3." class="small-thumb" src="./PMC3195022_files/saved_resource(2)" src-large="/pmc/articles/PMC3195022/table/T3/?report=previmg"></a><div class="icnblk_cntnt"><div><a class="figpopup" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/table/T3/" target="table" rid-figpopup="T3" rid-ob="ob-T3">Table 3.</a></div><!--caption a4--><div><span>Model-predicted pharmacokinetic parameters for the first dose of voriconazole, when given sequentially after fluconazole at various lag times after the last fluconazole dose</span></div></div></div></div><div id="__sec11" class="sec sec-last"><p></p><h3 class="inline">Tolerability and safety. </h3><p id="__p35" class="p p-first-last">There were no serious adverse events or discontinuations during the study. All 10 subjects had at least one adverse event, with the majority (25/27) being treatment related. Most treatment-related events (26/27) were mild (<em>n</em> = 15) or moderate (<em>n</em> = 11) in intensity. The most common adverse events were photophobia, abnormal vision, headache, alopecia, and diarrhea. The numbers of subjects experiencing an adverse event were similar in both treatment arms, although slightly fewer adverse events were reported during treatment with voriconazole plus fluconazole (14 versus 11 treatment-related adverse events). No apparent clinically significant concerns were identified in safety laboratory tests, vital signs, and electrocardiogram evaluations.</p></div></div><div id="__sec12" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-15"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-16">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec12title" style="text-transform: uppercase;">DISCUSSION</h2><p id="__p36" class="p p-first">The results of this clinical study suggest that concomitant administration of fluconazole and voriconazole significantly increases plasma voriconazole concentrations in CYP2C19 EMs. Although the sample size was small for PMs, the pharmacokinetics of voriconazole appeared to be unaffected by fluconazole in that population. This observation is not surprising, since the innate metabolic activity of CYP2C19 is already impaired in PMs and administration of a CYP2C19 inhibitor is unlikely to cause a further reduction in enzyme activity. On the basis of these observations, concomitant administration of these two antifungals should be avoided. Despite the small sample size and the fact that the study was conducted in healthy volunteers, the overall conclusions should be applicable to the larger patient population. The agreement between the observed pharmacokinetic parameters and those predicted by the PBPK model while simulating the clinical study provided adequate justification for the use of this model. PBPK simulations of sequential use suggested that the influence of fluconazole on systemic levels of voriconazole would persist for at least 24 h after the last dose of fluconazole.</p><p id="__p37">Fluconazole is categorized as a potent inhibitor of CYP2C9 and CPY2C19, as well as a moderate inhibitor of CYP3A4. Fluconazole's effect on voriconazole pharmacokinetics is probably due to its inhibition of CPY2C19, since voriconazole metabolism is mainly mediated by CYP2C19, followed by CYP3A4, with CYP2C9 appearing to play only a minimal role (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121444" role="button" aria-expanded="false" aria-haspopup="true">3</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121461" role="button" aria-expanded="false" aria-haspopup="true">9</a>). Omeprazole is another potent competitive inhibitor of CYP2C19 (<em>K<sub>i</sub></em>, 3.1 μM), but it has less of an effect on CYP3A4 (<em>K<sub>i</sub></em>, 84 μM) (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121449" role="button" aria-expanded="false" aria-haspopup="true">6</a>). In a previous study, concomitant omeprazole increased the average AUC of voriconazole by about 40% (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B32" rid="B32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121451" role="button" aria-expanded="false" aria-haspopup="true">32</a>); however, the magnitude of this increase does not require adjustments in the voriconazole dose when coadministered with omeprazole (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B17" rid="B17" class=" bibr popnode" role="button" aria-expanded="false" aria-haspopup="true">17</a>). In contrast, fluconazole inhibits CYP2C19 and CYP3A4 with <em>K<sub>i</sub></em>s of 2.1 μM and 25.2 μM (mean of the values reported in the literature), respectively (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121454" role="button" aria-expanded="false" aria-haspopup="true">4</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121443" role="button" aria-expanded="false" aria-haspopup="true">8</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121440" role="button" aria-expanded="false" aria-haspopup="true">10</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B31" rid="B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121446" role="button" aria-expanded="false" aria-haspopup="true">31</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B34" rid="B34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121475" role="button" aria-expanded="false" aria-haspopup="true">34</a>), and hence, it is not unexpected that its overall effect on voriconazole levels is greater than that of omeprazole.</p><p id="__p38">Interestingly, in this population of healthy Asian volunteers, the considerable intersubject variability in voriconazole pharmacokinetics was reduced when voriconazole was coadministered with fluconazole compared with the variability in pharmacokinetics when voriconazole was administered alone. This presumably occurred because the inhibition of CYP2C19 by fluconazole caused EM subjects to behave in a similar fashion to PM subjects in this respect. Nevertheless, the systemic exposure to voriconazole when given along with fluconazole observed in EMs did not exceed that observed in PMs. In clinical practice, voriconazole is administered to both EMs and PMs at an identical dose. On the basis of these results, it is tempting to deduce that concomitant fluconazole could be used as a booster to achieve therapeutic levels of voriconazole with doses lower than those currently recommended, to allow once-daily voriconazole dosing, or to reduce the intersubject variability in voriconazole pharmacokinetics. Although this approach seems attractive, there are several factors that require additional consideration. First, the optimum dose of fluconazole needed to boost voriconazole levels is currently unknown. Second, fluconazole alters the shape of the concentration-time curve and markedly increases voriconazole trough concentrations, which have been linked to a higher incidence of voriconazole-associated toxicity (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121466" role="button" aria-expanded="false" aria-haspopup="true">24</a>). Third, an additional microbiologic benefit with the concomitant use of both drugs is very unlikely (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121474" role="button" aria-expanded="false" aria-haspopup="true">23</a>), especially if the patient has not responded to prior fluconazole therapy. Finally, there is also a greater likelihood that patients will experience drug-drug interactions and adverse events with both agents combined than with either agent alone. Concomitant administration of voriconazole with fluconazole is therefore not recommended at present until additional dose-finding studies are conducted to evaluate the efficacy and safety of specific voriconazole-plus-fluconazole dosing regimens in the relevant therapeutic settings.</p><p id="__p39">No clinically significant safety concerns were noted during coadministration of voriconazole and fluconazole in healthy volunteers in the present study. However, elevated voriconazole plasma levels are associated with an increased likelihood of visual side effects and possible increases in hepatic enzymes (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121457" role="button" aria-expanded="false" aria-haspopup="true">5</a>, <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121476" role="button" aria-expanded="false" aria-haspopup="true">24</a>). Therapeutic drug monitoring of voriconazole suggests that trough concentrations greater than 6 μg/ml may be associated with a higher incidence of adverse events (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121459" role="button" aria-expanded="false" aria-haspopup="true">13</a>). A fluconazole-mediated increase in voriconazole levels would put patients at risk of exceeding this threshold. The PBPK model predicted that in a sequential use scenario, fluconazole would continue to have a substantial effect on voriconazole pharmacokinetics for at least 24 h after fluconazole discontinuation. However, it should be noted that voriconazole accumulates after multiple dosing (<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_235121468" role="button" aria-expanded="false" aria-haspopup="true">7</a>) and that the plasma voriconazole levels seen on the first day of fluconazole-voriconazole sequential therapy are expected to be below those seen at steady state. This would diminish some of the risks associated with a fluconazole-mediated increase in voriconazole levels during sequential use in clinical practice. However, it is prudent to regularly monitor patients for voriconazole-associated adverse events during overlapping exposure to fluconazole, especially if the affected patients receive additional concomitant drugs that inhibit CYP isozymes involved in voriconazole metabolism. This is not an unlikely scenario, given the often serious underlying conditions in patients with systemic fungal infection, requiring the administration of multiple comedications.</p><p id="__p40" class="p p-last">In conclusion, the results of this study show that concomitantly administered fluconazole significantly increases plasma levels of voriconazole. Therefore, concomitant use of fluconazole and voriconazole is not recommended until it has been further evaluated in clinical trials. Frequent monitoring for voriconazole-related adverse events is advisable if voriconazole is used sequentially after fluconazole, especially when voriconazole is initiated within 24 h of the last fluconazole dose.</p></div><div id="__ackid823206" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-17"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-18">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__ackid823206title" style="text-transform: uppercase;">ACKNOWLEDGMENTS</h2><div class="sec"><p id="__p42">This study was sponsored by Pfizer Inc. Editorial support was provided by Dominik Wolf of Parexel and was funded by Pfizer Inc.</p><p id="__p43">We thank Maurice Dickins (Pfizer) and Sharon Ripp (Pfizer) for their assistance with the pharmacokinetic modeling and simulations.</p><p id="__p44">B. Damle and M. V. Varma are full-time employees of Pfizer Inc. N. Wood was a full-time employee of Pfizer Inc. at the time that the pharmacokinetic study was conducted.</p></div></div><div id="__fn-groupid823192" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-19"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-20">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__fn-groupid823192title" style="text-transform: uppercase;">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="FN2"><sup>▿</sup>Published ahead of print on 29 August 2011.</p></div></div><div id="__ref-listid175058" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container" id="ui-jig-21"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true" id="ui-jig-22">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__ref-listid175058title" style="text-transform: uppercase;">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="B1">1. <span class="mixed-citation">
Andrews E., et al.  2008.  <span class="ref-title">Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects</span>. <span class="ref-journal">Br. J. Pharmacol.</span> <span class="ref-vol">65</span>:531–539 <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291369/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18294327" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B2">2. <span class="mixed-citation">
European Medicines Agency 2009.  <span class="ref-title">Vfend: EPAR–product information (last updated January 2011)</span>. European Medicines Agency, London, United Kingdom:  <a href="http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000387/human_med_001135.jsp&amp;murl=menus/medicines/medicines.jsp&amp;mid=WC0b01ac058001d125" ref="reftype=extlink&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="pmc_ext">http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000387/human_med_001135.jsp&amp;murl=menus/medicines/medicines.jsp&amp;mid=WC0b01ac058001d125</a> Accessed 11 March 2011</span></div><div class="ref-cit-blk half_rhythm" id="B3">3. <span class="mixed-citation">
Hyland R., Jones B. C., Smith D. A. 2003.  <span class="ref-title">Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole</span>. <span class="ref-journal">Drug Metab. Dispos.</span> <span class="ref-vol">31</span>:540–547  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12695341" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B4">4. <span class="mixed-citation">
Iatsimirskaia E., et al.  1997.  <span class="ref-title">Metabolism of rifabutin in human enterocyte and liver microsomes: kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents</span>. <span class="ref-journal">Clin. Pharmacol. Ther.</span> <span class="ref-vol">61</span>:554–562  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9164417" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B5">5. <span class="mixed-citation">
Imhof A., Schaer D. J., Schanz U., Schwarz U. 2006.  <span class="ref-title">Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring</span>. <span class="ref-journal">Swiss Med. Wkly.</span> <span class="ref-vol">136</span>:739–742  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17183438" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B6">6. <span class="mixed-citation">
Ko J.-W., Sukhova N., Thacker D., Chen P., Flockhart D. A. 1997.  <span class="ref-title">Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms</span>. <span class="ref-journal">Drug Metab. Dispos.</span> <span class="ref-vol">25</span>:853–862  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9224780" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B7">7. <span class="mixed-citation">
Lazarus H. M., Blumer J. L., Yanovich S., Schlamm H., Romero A. 2002.  <span class="ref-title">Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study</span>. <span class="ref-journal">J. Clin. Pharmacol.</span> <span class="ref-vol">42</span>:395–402  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/11936564" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B8">8. <span class="mixed-citation">
Maurice M., et al.  1992.  <span class="ref-title">Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture</span>. <span class="ref-journal">FASEB J.</span> <span class="ref-vol">6</span>:752–758  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/1371482" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B9">9. <span class="mixed-citation">
Murayama N., Imai N., Nakane T., Shimizu M., Yamazaki H. 2007.  <span class="ref-title">Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes</span>. <span class="ref-journal">Biochem. Pharmacol.</span> <span class="ref-vol">73</span>:2020–2026  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17433262" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B10">10. <span class="mixed-citation">
Nielsen T. L., Rasmussen B. B., Flinois J. P., Beaune P., Brosen K. 1999.  <span class="ref-title">In vitro metabolism of quinidine: the (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes</span>. <span class="ref-journal">J. Pharmacol. Exp. Ther.</span> <span class="ref-vol">289</span>:31–37  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/10086984" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B11">11. <span class="mixed-citation">
Nivoix Y., et al.  2008.  <span class="ref-title">The enzymatic basis of drug-drug interactions with systemic triazole antifungals</span>. <span class="ref-journal">Clin. Pharmacokinet.</span> <span class="ref-vol">47</span>:779–792  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/19026034" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B12">12. <span class="mixed-citation">
Niwa T., Shiraga T., Takagi A. 2005.  <span class="ref-title">Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes</span>. <span class="ref-journal">Biol. Pharm. Bull.</span> <span class="ref-vol">28</span>:1805–1808  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16141567" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B13">13. <span class="mixed-citation">
Pascual A., et al.  2008.  <span class="ref-title">Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes</span>. <span class="ref-journal">Clin. Infect. Dis.</span> <span class="ref-vol">46</span>:201–211  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18171251" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B14">14. <span class="mixed-citation">
Pemán J., et al.  2006.  <span class="ref-title">Voriconazole in the management of nosocomial invasive fungal infections</span>. <span class="ref-journal">Ther. Clin. Risk Manag.</span> <span class="ref-vol">2</span>:129–158 <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1661660/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18360588" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B15">15. <span class="mixed-citation">
Pfaller M. A., Messer S. A., Hollis R. J., Jones R. N., Diekema D. J. 2002.  <span class="ref-title"><em>In vitro</em> activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp</span>. <span class="ref-journal">Antimicrob. Agents Chemother.</span> <span class="ref-vol">46</span>:1723–1727 <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC127275/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12019081" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B16">16. <span class="mixed-citation">
Pfizer Inc 2010.  <span class="ref-title">Diflucan—U.S. prescribing information (revised January 2010)</span>. Pfizer Inc., New York, NY</span></div><div class="ref-cit-blk half_rhythm" id="B17">17. <span class="mixed-citation">
Pfizer Inc 2010.  <span class="ref-title">Vfend—U.S. prescribing information (revised June 2010)</span>. Pfizer Inc., New York, NY</span></div><div class="ref-cit-blk half_rhythm" id="B18">18. <span class="mixed-citation">
Prentice A. G., et al.  2008.  <span class="ref-title">Guidelines on the management of invasive fungal infection during therapy for haematological malignancy. BCSH guidelines home page</span>. Pfizer Inc., New York, NY</span></div><div class="ref-cit-blk half_rhythm" id="B19">19. <span class="mixed-citation">
Purkins L., et al.  2002.  <span class="ref-title">Pharmacokinetics and safety of voriconazole following intravenous-to oral-dose escalation regimens</span>. <span class="ref-journal">Antimicrob. Agents Chemother.</span> <span class="ref-vol">46</span>:2546–2553 <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC127341/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12121931" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B20">20. <span class="mixed-citation">
Purkins L., Wood N., Greenhalgh K., Allen M. J., Oliver S. D. 2003.  <span class="ref-title">Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety</span>. <span class="ref-journal">Br. J. Clin. Pharmacol</span>. <span class="ref-vol">56</span>(<span class="ref-iss">Suppl.1</span>):10–16 <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884314/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/14616408" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B21">21. <span class="mixed-citation">
Ruhnke M., Schmidt-Westhausen A., Trautmann M. 1997.  <span class="ref-title"><em>In vitro</em> activities of voriconazole (UK-109,496) against fluconazole-susceptible and-resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection</span>. <span class="ref-journal">Antimicrob. Agents Chemother.</span> <span class="ref-vol">41</span>:575–577 <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC163753/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9055995" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B22">22. <span class="mixed-citation">
Scholz I., et al.  2009.  <span class="ref-title">Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype</span>. <span class="ref-journal">Br. J. Clin. Pharmacol.</span> <span class="ref-vol">68</span>:906–915 <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2810802/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/20002085" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B23">23. <span class="mixed-citation">
Segal B. H., Steinbach W. J. 2007.  <span class="ref-title">Combination antifungals: an update</span>. <span class="ref-journal">Expert Rev. Anti Infect. Ther.</span> <span class="ref-vol">5</span>:883–892  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17914921" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B24">24. <span class="mixed-citation">
Tan K., Brayshaw N., Tomaszewski K., Troke P., Wood N. 2006.  <span class="ref-title">Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities</span>. <span class="ref-journal">J. Clin. Pharmacol.</span> <span class="ref-vol">46</span>:235–243  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16432276" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B25">25. <span class="mixed-citation">
Theuretzbacher U., Ihle F., Derendorf H. 2006.  <span class="ref-title">Pharmacokinetic/pharmacodynamic profile of voriconazole</span>. <span class="ref-journal">Clin. Pharmacokinet.</span> <span class="ref-vol">45</span>:649–663  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16802848" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B26">26. <span class="mixed-citation">
Thursky K. A., et al.  2008.  <span class="ref-title">Recommendations for the treatment of established fungal infections</span>. <span class="ref-journal">Intern. Med. J.</span> <span class="ref-vol">38</span>:496–520  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18588522" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B27">27. <span class="mixed-citation">
Venkatakrishnan K., von Moltke L. L., Greenblatt D. J. 2000.  <span class="ref-title">Effects of the antifungal agents on oxidative drug metabolism: clinical relevance</span>. <span class="ref-journal">Clin. Pharmacokinet.</span> <span class="ref-vol">38</span>:111–180  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/10709776" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B28">28. <span class="mixed-citation">
Walsh T. J., et al.  2008.  <span class="ref-title">Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America</span>. <span class="ref-journal">Clin. Infect. Dis.</span> <span class="ref-vol">46</span>:327–360  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18177225" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B29">29. <span class="mixed-citation">
Wang G., et al.  2009.  <span class="ref-title">The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers</span>. <span class="ref-journal">Eur. J. Clin. Pharmacol.</span> <span class="ref-vol">65</span>:281–285  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18982321" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B30">30. <span class="mixed-citation">
Weiss J., et al.  2009.  <span class="ref-title">CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole</span>. <span class="ref-journal">J. Clin. Pharmacol.</span> <span class="ref-vol">49</span>:196–204  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/19033450" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B31">31. <span class="mixed-citation">
Wienkers L. C., et al.  1996.  <span class="ref-title">Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19</span>. <span class="ref-journal">Drug Metab. Dispos.</span> <span class="ref-vol">24</span>:610–614  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8723744" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B32">32. <span class="mixed-citation">
Wood, et al.  2003.  <span class="ref-title">Effect of omeprazole on the steady-state pharmacokinetics of voriconazole</span>. <span class="ref-journal">Br. J. Clin. Pharmacol.</span> <span class="ref-vol">56</span>(<span class="ref-iss">Suppl. 1</span>):56–61 <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1884317/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/14616415" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B33">33. <span class="mixed-citation">
Xiao Z.-S., et al.  1997.  <span class="ref-title">Differences in the incidence of the <em>CYP2C19</em> polymorphism affecting the S-methenytoin phenotype in Chinese Han and Bai populations and identification of a new rare <em>CYP2C19</em> mutant allele</span>. <span class="ref-journal">J. Pharmacol. Exp. Ther.</span> <span class="ref-vol">281</span>:604–609  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9103550" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="B34">34. <span class="mixed-citation">
Yamazaki H., Nakamoto M., Shimizu M., Murayama N., Niwa T. 2010.  <span class="ref-title">Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles</span>. <span class="ref-journal">Br. J. Clin. Pharmacol.</span> <span class="ref-vol">69</span>:593–597 <span class="nowrap ref pmc">[<a class="int-reflink" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883751/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="http://www.ncbi.nlm.nih.gov/pubmed/20565450" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#__abstractid794491title">Abstract</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#__sec1title">INTRODUCTION</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#__sec2title">MATERIALS AND METHODS</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#__sec7title">RESULTS</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#__sec12title">DISCUSSION</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#__ackid823206title">ACKNOWLEDGMENTS</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#__fn-groupid823192title">Footnotes</a></li><li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#__ref-listid175058title">REFERENCES</a></li></ul></div></div><!--post-content--><hr class="whole_rhythm no_bottom_margin"><div class="courtesy-note no_margin small">Articles from <span class="acknowledgment-journal-title">Antimicrobial Agents and Chemotherapy</span> are provided here courtesy of <strong>American Society for Microbiology (ASM)</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="try-button"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/?report=reader"><img src="./PMC3195022_files/3838809" alt="PubReader format: click here to try"></a></div><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/epub/">ePub (beta)</a></li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/pdf/zac5172.pdf">PDF (371K)</a></li> | <li><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" data-citationid="PMC3195022" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3195022%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC3195022_files/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3195022%2F&amp;text=Pharmacokinetics%20of%20Voriconazole%20Administered%20Concomitantly%20with%20Fluconazole%20and%20Population-Based%20Simulation%20for%20Sequential%20Use%20" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC3195022_files/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3195022%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="./PMC3195022_files/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="21876043" data-aiid="3195022" data-aid="3195022" data-iid="201205" data-domainid="82" data-domain="aac" data-accid="PMC3195022" data-md5="3d99d0fe529b43b3afebe3f8ee9db5c2">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="pmfavad" toggles="ui-portlet_content-25" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-25" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input type="hidden" name="absid" id="absid" value="3195022"><div id="pubmed_favoritesad" class="empty" data-db="pmc">
<span role="menubar"><div class="ui-ncbisetswitch ltd-hover" role="menuitem" aria-expanded="false" aria-haspopup="true"><a href="http://www.ncbi.nlm.nih.gov/myncbi/collections/" class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" id="favList" data-jigconfig="destSelector:&#39;#favUL&#39;,starExists:true,createCollectionUrl:&#39;#&#39;,manageCollectionsUrl:&#39;/myncbi/collections/&#39;"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" title="View more options" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper"><ul id="favUL" class="ui-ncbisetswitch-options"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="http://www.ncbi.nlm.nih.gov/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input type="submit" class="button_apply" name="addtocollection" value="1"></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" toggles="ui-portlet_content-27" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-27" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/23400742" ref="reftype=relart&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Pharmacokinetics and short-term safety of etravirine in combination with fluconazole or voriconazole in HIV-negative volunteers.</a><span class="source">[J Clin Pharmacol. 2013]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-29" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kakuda TN, Van Solingen-Ristea R, Aharchi F, Smedt GD, Witek J, Nijs S, Vyncke V, Hoetelmans RM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">J Clin Pharmacol. 2013 Jan; 53(1):41-50. Epub 2013 Jan 24.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/19299322" ref="reftype=relart&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Lack of effect of Ginkgo biloba on voriconazole pharmacokinetics in Chinese volunteers identified as CYP2C19 poor and extensive metabolizers.</a><span class="source">[Ann Pharmacother. 2009]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-31" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lei HP, Wang G, Wang LS, Ou-yang DS, Chen H, Li Q, Zhang W, Tan ZR, Fan L, He YJ, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ann Pharmacother. 2009 Apr; 43(4):726-31. Epub 2009 Mar 18.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/16890574" ref="reftype=relart&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir.</a><span class="source">[Clin Pharmacol Ther. 2006]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-33" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mikus G, Schöwel V, Drzewinska M, Rengelshausen J, Ding R, Riedel KD, Burhenne J, Weiss J, Thomsen T, Haefeli WE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Pharmacol Ther. 2006 Aug; 80(2):126-35. Epub 2006 Jul 3.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/16205037" ref="reftype=relart&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">[Drug-drug interaction of antifungal drugs].</a><span class="source">[Yakugaku Zasshi. 2005]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-35" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Niwa T, Shiraga T, Takagi A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Yakugaku Zasshi. 2005 Oct; 125(10):795-805. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/12867215" ref="reftype=relart&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Voriconazole.</a><span class="source">[Clin Ther. 2003]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-37" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Jeu L, Piacenti FJ, Lyakhovetskiy AG, Fung HB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Ther. 2003 May; 25(5):1321-81. </em>
</div>
</li>
</ul>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=21876043&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=21876043&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Cited by other articles in PMC</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-39" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-39" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613950/" ref="reftype=relart&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification</a><span class="source">[Drug Metabolism and Dispositio...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-41" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sager JE, Yu J, Ragueneau-Majlessi I, Isoherranen N. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Drug Metabolism and Disposition. 2015 Nov; 43(11)1823-1837</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4136065/" ref="reftype=relart&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Population Pharmacokinetic Analysis of Voriconazole and Anidulafungin in Adult Patients with Invasive Aspergillosis</a><span class="source">[Antimicrobial Agents and Chemo...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-43" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Liu P, Mould DR. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Antimicrobial Agents and Chemotherapy. 2014 Aug; 58(8)4718-4726</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809903/" ref="reftype=relart&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Applications of Pharmacometrics in the Clinical Development and Pharmacotherapy of Anti-Infectives</a><span class="source">[Expert review of clinical phar...]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-45" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Trivedi A, Lee RE, Meibohm B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Expert review of clinical pharmacology. 2013 Mar; 6(2)10.1586/ecp.13.6</em>
</div>
</li>
</ul>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/citedby/" ref="reftype=relart&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|CitedBy&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-47" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-47" aria-hidden="false"><ul>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/?Db=pccompound&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pccompound&amp;IdsFromResult=3195022" ref="reftype=Compound&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Compound&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Compound</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-49" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Compound<div class="brieflinkpopdesc">PubChem Compound links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/?Db=medgen&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_medgen&amp;IdsFromResult=3195022" ref="reftype=MedGen&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">MedGen</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-51" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">MedGen<div class="brieflinkpopdesc">Related information in MedGen</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pubmed/21876043/" ref="reftype=PubMed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">PubMed</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-53" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/?Db=pcsubstance&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pcsubstance&amp;IdsFromResult=3195022" ref="reftype=Substance&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Substance&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Substance</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-55" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Substance<div class="brieflinkpopdesc">PubChem Substance links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="http://www.ncbi.nlm.nih.gov/pmc/?Db=taxonomy&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_taxonomy&amp;IdsFromResult=3195022" ref="reftype=Taxonomy&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Taxonomy&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Taxonomy</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-57" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Taxonomy<div class="brieflinkpopdesc">Related taxonomy entry</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a name="Shutter" sid="1" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" toggles="ui-portlet_content-59" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-59" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="">
<div class="action">
<a href="javascript:historyDisplayState(&#39;ClearHT&#39;)">Clear</a><a href="javascript:historyDisplayState(&#39;HTOff&#39;)" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState(&#39;HTOn&#39;)" class="HTOff">Turn On</a>
</div>
<ul id="activity">
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c2aeef0c03b79817606b2">Pharmacokinetics of Voriconazole Administered Concomitantly with Fluconazole and...</a><div class="ralinkpop offscreen_noflow">Pharmacokinetics of Voriconazole Administered Concomitantly with Fluconazole and Population-Based Simulation for Sequential Use <div class="brieflinkpopdesc">Antimicrobial Agents and Chemotherapy. 2011 Nov; 55(11)5172</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_qry two_line">
<a class="htb" ref="log$=activity&amp;linkpos=2" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c2aec04fcfad591773c41">PMC3195022 <span class="number">(1)</span></a><div class="tertiary">PMC</div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=3" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c2ada04fcfad59177395e">Editor's choice: Impact of common genetic variation on response to simvastatin t...</a><div class="ralinkpop offscreen_noflow">Editor's choice: Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study<div class="brieflinkpopdesc">European Heart Journal. 2013 Apr 1; 34(13)982</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_qry two_line">
<a class="htb" ref="log$=activity&amp;linkpos=4" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c2ad8f0c03b79817602fe">PMC3612775 <span class="number">(1)</span></a><div class="tertiary">PMC</div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=5" href="http://www.ncbi.nlm.nih.gov/portal/utils/pageresolver.fcgi?recordid=576c2abd7fd84438f0ea7c98">Differential Effects of Tipranavir plus Ritonavir on Atorvastatin or Rosuvastati...</a><div class="ralinkpop offscreen_noflow">Differential Effects of Tipranavir plus Ritonavir on Atorvastatin or Rosuvastatin Pharmacokinetics in Healthy Volunteers <div class="brieflinkpopdesc">Antimicrobial Agents and Chemotherapy. 2009 Oct; 53(10)4385</div>
</div>
<div class="tertiary"></div>
</li>
</ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState(&#39;HTOn&#39;)">Turn recording back on</a></p>
<a class="seemore" href="http://www.ncbi.nlm.nih.gov/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p3" name="crb--__p3" rid="__p3" style="position: absolute; visibility: visible; width: 370px; top: 952px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-61"><ul>
<li class="two_line" reference_id="B7">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/11936564/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study.</a><span class="one_line_source">[J Clin Pharmacol.  2002]</span><div class="alt-note">
<div class="authors">Lazarus HM, Blumer JL, Yanovich S, Schlamm H, Romero A</div>
<div class="citation">J Clin Pharmacol. 2002 Apr; 42(4):395-402.</div>
</div>
</li>
<li class="two_line" reference_id="B19">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12121931/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens.</a><span class="one_line_source">[Antimicrob Agents Chemother.  2002]</span><div class="alt-note">
<div class="authors">Purkins L, Wood N, Ghahramani P, Greenhalgh K, Allen MJ, Kleinermans D</div>
<div class="citation">Antimicrob Agents Chemother. 2002 Aug; 46(8):2546-53.</div>
</div>
</li>
<li class="two_line" reference_id="B20">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/14616408/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety.</a><span class="one_line_source">[Br J Clin Pharmacol.  2003]</span><div class="alt-note">
<div class="authors">Purkins L, Wood N, Greenhalgh K, Allen MJ, Oliver SD</div>
<div class="citation">Br J Clin Pharmacol. 2003 Dec; 56 Suppl 1():10-6.</div>
</div>
</li>
<li class="two_line" reference_id="B3" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12695341/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole.</a><span class="one_line_source">[Drug Metab Dispos.  2003]</span><div class="alt-note">
<div class="authors">Hyland R, Jones BC, Smith DA</div>
<div class="citation">Drug Metab Dispos. 2003 May; 31(5):540-7.</div>
</div>
</li>
<li class="two_line" reference_id="B22" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/20002085/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype.</a><span class="one_line_source">[Br J Clin Pharmacol.  2009]</span><div class="alt-note">
<div class="authors">Scholz I, Oberwittler H, Riedel KD, Burhenne J, Weiss J, Haefeli WE, Mikus G</div>
<div class="citation">Br J Clin Pharmacol. 2009 Dec; 68(6):906-15.</div>
</div>
</li>
<li class="two_line" reference_id="B29" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18982321/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers.</a><span class="one_line_source">[Eur J Clin Pharmacol.  2009]</span><div class="alt-note">
<div class="authors">Wang G, Lei HP, Li Z, Tan ZR, Guo D, Fan L, Chen Y, Hu DL, Wang D, Zhou HH</div>
<div class="citation">Eur J Clin Pharmacol. 2009 Mar; 65(3):281-5.</div>
</div>
</li>
<li class="two_line" reference_id="B30" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/19033450/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole.</a><span class="one_line_source">[J Clin Pharmacol.  2009]</span><div class="alt-note">
<div class="authors">Weiss J, Ten Hoevel MM, Burhenne J, Walter-Sack I, Hoffmann MM, Rengelshausen J, Haefeli WE, Mikus G</div>
<div class="citation">J Clin Pharmacol. 2009 Feb; 49(2):196-204.</div>
</div>
</li>
<li class="two_line" reference_id="B11" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/19026034/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> The enzymatic basis of drug-drug interactions with systemic triazole antifungals.</a><span class="one_line_source">[Clin Pharmacokinet.  2008]</span><div class="alt-note">
<div class="authors">Nivoix Y, Levêque D, Herbrecht R, Koffel JC, Beretz L, Ubeaud-Sequier G</div>
<div class="citation">Clin Pharmacokinet. 2008; 47(12):779-92.</div>
</div>
</li>
<li class="two_line" reference_id="B25" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/16802848/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Pharmacokinetic/pharmacodynamic profile of voriconazole.</a><span class="one_line_source">[Clin Pharmacokinet.  2006]</span><div class="alt-note">
<div class="authors">Theuretzbacher U, Ihle F, Derendorf H</div>
<div class="citation">Clin Pharmacokinet. 2006; 45(7):649-63.</div>
</div>
</li>
<li class="two_line" reference_id="B12" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/16141567/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes.</a><span class="one_line_source">[Biol Pharm Bull.  2005]</span><div class="alt-note">
<div class="authors">Niwa T, Shiraga T, Takagi A</div>
<div class="citation">Biol Pharm Bull. 2005 Sep; 28(9):1805-8.</div>
</div>
</li>
</ul><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p4" name="crb--__p4" rid="__p4" style="position: absolute; visibility: visible; width: 370px; top: 1110px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-62"><ul>
<li class="two_line" reference_id="B23">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17914921/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Combination antifungals: an update.</a><span class="one_line_source">[Expert Rev Anti Infect Ther.  2007]</span><div class="alt-note">
<div class="authors">Segal BH, Steinbach WJ</div>
<div class="citation">Expert Rev Anti Infect Ther. 2007 Oct; 5(5):883-92.</div>
</div>
</li>
<li class="two_line" reference_id="B26">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18588522/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Recommendations for the treatment of established fungal infections.</a><span class="one_line_source">[Intern Med J.  2008]</span><div class="alt-note">
<div class="authors">Thursky KA, Playford EG, Seymour JF, Sorrell TC, Ellis DH, Guy SD, Gilroy N, Chu J, Shaw DR</div>
<div class="citation">Intern Med J. 2008 Jun; 38(6b):496-520.</div>
</div>
</li>
<li class="two_line" reference_id="B28">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18177225/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.</a><span class="one_line_source">[Clin Infect Dis.  2008]</span><div class="alt-note">
<div class="authors">Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF, Infectious Diseases Society of America</div>
<div class="citation">Clin Infect Dis. 2008 Feb 1; 46(3):327-60.</div>
</div>
</li>
<li class="two_line" reference_id="B14">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18360588/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Voriconazole in the management of nosocomial invasive fungal infections.</a><span class="one_line_source">[Ther Clin Risk Manag.  2006]</span><div class="alt-note">
<div class="authors">Pemán J, Salavert M, Cantón E, Jarque I, Romá E, Zaragoza R, Viudes A, Gobernado M</div>
<div class="citation">Ther Clin Risk Manag. 2006 Jun; 2(2):129-58.</div>
</div>
</li>
<li class="two_line" reference_id="B15">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12019081/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.</a><span class="one_line_source">[Antimicrob Agents Chemother.  2002]</span><div class="alt-note">
<div class="authors">Pfaller MA, Messer SA, Hollis RJ, Jones RN, Diekema DJ</div>
<div class="citation">Antimicrob Agents Chemother. 2002 Jun; 46(6):1723-7.</div>
</div>
</li>
<li class="two_line" reference_id="B21">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/9055995/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection.</a><span class="one_line_source">[Antimicrob Agents Chemother.  1997]</span><div class="alt-note">
<div class="authors">Ruhnke M, Schmidt-Westhausen A, Trautmann M</div>
<div class="citation">Antimicrob Agents Chemother. 1997 Mar; 41(3):575-7.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p5" name="crb--__p5" rid="__p5" style="position: absolute; visibility: visible; width: 370px; top: 1373px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-63"><ul><li class="two_line" reference_id="B27">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/10709776/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.</a><span class="one_line_source">[Clin Pharmacokinet.  2000]</span><div class="alt-note">
<div class="authors">Venkatakrishnan K, von Moltke LL, Greenblatt DJ</div>
<div class="citation">Clin Pharmacokinet. 2000 Feb; 38(2):111-80.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p9" name="crb--__p9" rid="__p9" style="position: absolute; visibility: visible; width: 370px; top: 2066px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-64"><ul><li class="two_line" reference_id="B33">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/9103550/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele.</a><span class="one_line_source">[J Pharmacol Exp Ther.  1997]</span><div class="alt-note">
<div class="authors">Xiao ZS, Goldstein JA, Xie HG, Blaisdell J, Wang W, Jiang CH, Yan FX, He N, Huang SL, Xu ZH, Zhou HH</div>
<div class="citation">J Pharmacol Exp Ther. 1997 Apr; 281(1):604-9.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p10" name="crb--__p10" rid="__p10" style="position: absolute; visibility: visible; width: 370px; top: 2182px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-65"><ul><li class="two_line" reference_id="B1">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18294327/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects.</a><span class="one_line_source">[Br J Clin Pharmacol.  2008]</span><div class="alt-note">
<div class="authors">Andrews E, Damle BD, Fang A, Foster G, Crownover P, LaBadie R, Glue P</div>
<div class="citation">Br J Clin Pharmacol. 2008 Apr; 65(4):531-9.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p13" name="crb--__p13" rid="__p13" style="position: absolute; visibility: visible; width: 370px; top: 2694px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-66"><ul>
<li class="two_line" reference_id="B3">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12695341/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole.</a><span class="one_line_source">[Drug Metab Dispos.  2003]</span><div class="alt-note">
<div class="authors">Hyland R, Jones BC, Smith DA</div>
<div class="citation">Drug Metab Dispos. 2003 May; 31(5):540-7.</div>
</div>
</li>
<li class="two_line" reference_id="B9">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17433262/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.</a><span class="one_line_source">[Biochem Pharmacol.  2007]</span><div class="alt-note">
<div class="authors">Murayama N, Imai N, Nakane T, Shimizu M, Yamazaki H</div>
<div class="citation">Biochem Pharmacol. 2007 Jun 15; 73(12):2020-6.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p16" name="crb--__p16" rid="__p16" style="display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-67"><ul>
<li class="expanded" reference_id="B3">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12695341/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole.</a><span class="one_line_source">[Drug Metab Dispos.  2003]</span><div class="alt-note">
<div class="authors">Hyland R, Jones BC, Smith DA</div>
<div class="citation">Drug Metab Dispos. 2003 May; 31(5):540-7.</div>
</div>
</li>
<li class="expanded" reference_id="B9">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17433262/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.</a><span class="one_line_source">[Biochem Pharmacol.  2007]</span><div class="alt-note">
<div class="authors">Murayama N, Imai N, Nakane T, Shimizu M, Yamazaki H</div>
<div class="citation">Biochem Pharmacol. 2007 Jun 15; 73(12):2020-6.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p17" name="crb--__p17" rid="__p17" style="position: absolute; visibility: visible; width: 370px; top: 2976px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-68"><ul>
<li class="two_line" reference_id="B31">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/8723744/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19.</a><span class="one_line_source">[Drug Metab Dispos.  1996]</span><div class="alt-note">
<div class="authors">Wienkers LC, Wurden CJ, Storch E, Kunze KL, Rettie AE, Trager WF</div>
<div class="citation">Drug Metab Dispos. 1996 May; 24(5):610-4.</div>
</div>
</li>
<li class="two_line" reference_id="B4" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/9164417/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolism of rifabutin in human enterocyte and liver microsomes: kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents.</a><span class="one_line_source">[Clin Pharmacol Ther.  1997]</span><div class="alt-note">
<div class="authors">Iatsimirskaia E, Tulebaev S, Storozhuk E, Utkin I, Smith D, Gerber N, Koudriakova T</div>
<div class="citation">Clin Pharmacol Ther. 1997 May; 61(5):554-62.</div>
</div>
</li>
<li class="two_line" reference_id="B8" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/1371482/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture.</a><span class="one_line_source">[FASEB J.  1992]</span><div class="alt-note">
<div class="authors">Maurice M, Pichard L, Daujat M, Fabre I, Joyeux H, Domergue J, Maurel P</div>
<div class="citation">FASEB J. 1992 Jan 6; 6(2):752-8.</div>
</div>
</li>
<li class="two_line" reference_id="B10" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/10086984/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">In vitro metabolism of quinidine: the (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes.</a><span class="one_line_source">[J Pharmacol Exp Ther.  1999]</span><div class="alt-note">
<div class="authors">Nielsen TL, Rasmussen BB, Flinois JP, Beaune P, Brosen K</div>
<div class="citation">J Pharmacol Exp Ther. 1999 Apr; 289(1):31-7.</div>
</div>
</li>
<li class="two_line" reference_id="B34" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/20565450/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles.</a><span class="one_line_source">[Br J Clin Pharmacol.  2010]</span><div class="alt-note">
<div class="authors">Yamazaki H, Nakamoto M, Shimizu M, Murayama N, Niwa T</div>
<div class="citation">Br J Clin Pharmacol. 2010 Jun; 69(6):593-7.</div>
</div>
</li>
</ul><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p37" name="crb--__p37" rid="__p37" style="position: absolute; visibility: visible; width: 370px; top: 5352px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-69"><ul>
<li class="two_line" reference_id="B3">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/12695341/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole.</a><span class="one_line_source">[Drug Metab Dispos.  2003]</span><div class="alt-note">
<div class="authors">Hyland R, Jones BC, Smith DA</div>
<div class="citation">Drug Metab Dispos. 2003 May; 31(5):540-7.</div>
</div>
</li>
<li class="two_line" reference_id="B9">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17433262/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.</a><span class="one_line_source">[Biochem Pharmacol.  2007]</span><div class="alt-note">
<div class="authors">Murayama N, Imai N, Nakane T, Shimizu M, Yamazaki H</div>
<div class="citation">Biochem Pharmacol. 2007 Jun 15; 73(12):2020-6.</div>
</div>
</li>
<li class="two_line" reference_id="B6">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/9224780/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms.</a><span class="one_line_source">[Drug Metab Dispos.  1997]</span><div class="alt-note">
<div class="authors">Ko JW, Sukhova N, Thacker D, Chen P, Flockhart DA</div>
<div class="citation">Drug Metab Dispos. 1997 Jul; 25(7):853-62.</div>
</div>
</li>
<li class="two_line" reference_id="B32">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/14616415/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effect of omeprazole on the steady-state pharmacokinetics of voriconazole.</a><span class="one_line_source">[Br J Clin Pharmacol.  2003]</span><div class="alt-note">
<div class="authors">Wood N, Tan K, Purkins L, Layton G, Hamlin J, Kleinermans D, Nichols D</div>
<div class="citation">Br J Clin Pharmacol. 2003 Dec; 56 Suppl 1():56-61.</div>
</div>
</li>
<li class="two_line" reference_id="B4" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/9164417/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Metabolism of rifabutin in human enterocyte and liver microsomes: kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents.</a><span class="one_line_source">[Clin Pharmacol Ther.  1997]</span><div class="alt-note">
<div class="authors">Iatsimirskaia E, Tulebaev S, Storozhuk E, Utkin I, Smith D, Gerber N, Koudriakova T</div>
<div class="citation">Clin Pharmacol Ther. 1997 May; 61(5):554-62.</div>
</div>
</li>
<li class="two_line" reference_id="B8" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/1371482/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture.</a><span class="one_line_source">[FASEB J.  1992]</span><div class="alt-note">
<div class="authors">Maurice M, Pichard L, Daujat M, Fabre I, Joyeux H, Domergue J, Maurel P</div>
<div class="citation">FASEB J. 1992 Jan 6; 6(2):752-8.</div>
</div>
</li>
<li class="two_line" reference_id="B10" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/10086984/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">In vitro metabolism of quinidine: the (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes.</a><span class="one_line_source">[J Pharmacol Exp Ther.  1999]</span><div class="alt-note">
<div class="authors">Nielsen TL, Rasmussen BB, Flinois JP, Beaune P, Brosen K</div>
<div class="citation">J Pharmacol Exp Ther. 1999 Apr; 289(1):31-7.</div>
</div>
</li>
<li class="two_line" reference_id="B31" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/8723744/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19.</a><span class="one_line_source">[Drug Metab Dispos.  1996]</span><div class="alt-note">
<div class="authors">Wienkers LC, Wurden CJ, Storch E, Kunze KL, Rettie AE, Trager WF</div>
<div class="citation">Drug Metab Dispos. 1996 May; 24(5):610-4.</div>
</div>
</li>
<li class="two_line" reference_id="B34" style="display: none;">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/20565450/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles.</a><span class="one_line_source">[Br J Clin Pharmacol.  2010]</span><div class="alt-note">
<div class="authors">Yamazaki H, Nakamoto M, Shimizu M, Murayama N, Niwa T</div>
<div class="citation">Br J Clin Pharmacol. 2010 Jun; 69(6):593-7.</div>
</div>
</li>
</ul><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/" class="seemore">See more ...</a></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p38" name="crb--__p38" rid="__p38" style="position: absolute; visibility: visible; width: 370px; top: 5577px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-70"><ul>
<li class="two_line" reference_id="B24">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/16432276/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities.</a><span class="one_line_source">[J Clin Pharmacol.  2006]</span><div class="alt-note">
<div class="authors">Tan K, Brayshaw N, Tomaszewski K, Troke P, Wood N</div>
<div class="citation">J Clin Pharmacol. 2006 Feb; 46(2):235-43.</div>
</div>
</li>
<li class="two_line" reference_id="B23">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17914921/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Combination antifungals: an update.</a><span class="one_line_source">[Expert Rev Anti Infect Ther.  2007]</span><div class="alt-note">
<div class="authors">Segal BH, Steinbach WJ</div>
<div class="citation">Expert Rev Anti Infect Ther. 2007 Oct; 5(5):883-92.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p39" name="crb--__p39" rid="__p39" style="position: absolute; visibility: visible; width: 370px; top: 6008px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-71"><ul>
<li class="two_line" reference_id="B5">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/17183438/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring.</a><span class="one_line_source">[Swiss Med Wkly.  2006]</span><div class="alt-note">
<div class="authors">Imhof A, Schaer DJ, Schanz U, Schwarz U</div>
<div class="citation">Swiss Med Wkly. 2006 Nov 11; 136(45-46):739-42.</div>
</div>
</li>
<li class="two_line" reference_id="B24">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/16432276/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities.</a><span class="one_line_source">[J Clin Pharmacol.  2006]</span><div class="alt-note">
<div class="authors">Tan K, Brayshaw N, Tomaszewski K, Troke P, Wood N</div>
<div class="citation">J Clin Pharmacol. 2006 Feb; 46(2):235-43.</div>
</div>
</li>
<li class="two_line" reference_id="B13">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/18171251/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.</a><span class="one_line_source">[Clin Infect Dis.  2008]</span><div class="alt-note">
<div class="authors">Pascual A, Calandra T, Bolay S, Buclin T, Bille J, Marchetti O</div>
<div class="citation">Clin Infect Dis. 2008 Jan 15; 46(2):201-11.</div>
</div>
</li>
<li class="two_line" reference_id="B7">
<a href="http://www.ncbi.nlm.nih.gov/pubmed/11936564/" ref="reftype=pubmed&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study.</a><span class="one_line_source">[J Clin Pharmacol.  2002]</span><div class="alt-note">
<div class="authors">Lazarus HM, Blumer JL, Yanovich S, Schlamm H, Romero A</div>
<div class="citation">J Clin Pharmacol. 2002 Apr; 42(4):395-402.</div>
</div>
</li>
</ul></div>
</div>
</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="./PMC3195022_files/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"><div id="body-link-popper-B7" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study.<div class="authors">Lazarus HM, Blumer JL, Yanovich S, Schlamm H, Romero A</div><div class="citation">J Clin Pharmacol. 2002 Apr; 42(4):395-402.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/11936564/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B7">Ref list</a>]</p></div><div id="body-link-popper-B19" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens.<div class="authors">Purkins L, Wood N, Ghahramani P, Greenhalgh K, Allen MJ, Kleinermans D</div><div class="citation">Antimicrob Agents Chemother. 2002 Aug; 46(8):2546-53.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12121931/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B19">Ref list</a>]</p></div><div id="body-link-popper-B20" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety.<div class="authors">Purkins L, Wood N, Greenhalgh K, Allen MJ, Oliver SD</div><div class="citation">Br J Clin Pharmacol. 2003 Dec; 56 Suppl 1():10-6.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/14616408/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B20">Ref list</a>]</p></div><div id="body-link-popper-B3" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole.<div class="authors">Hyland R, Jones BC, Smith DA</div><div class="citation">Drug Metab Dispos. 2003 May; 31(5):540-7.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12695341/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B3">Ref list</a>]</p></div><div id="body-link-popper-B22" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype.<div class="authors">Scholz I, Oberwittler H, Riedel KD, Burhenne J, Weiss J, Haefeli WE, Mikus G</div><div class="citation">Br J Clin Pharmacol. 2009 Dec; 68(6):906-15.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/20002085/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B22">Ref list</a>]</p></div><div id="body-link-popper-B29" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers.<div class="authors">Wang G, Lei HP, Li Z, Tan ZR, Guo D, Fan L, Chen Y, Hu DL, Wang D, Zhou HH</div><div class="citation">Eur J Clin Pharmacol. 2009 Mar; 65(3):281-5.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18982321/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B29">Ref list</a>]</p></div><div id="body-link-popper-B30" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">CYP2C19 genotype is a major factor contributing to the highly variable pharmacokinetics of voriconazole.<div class="authors">Weiss J, Ten Hoevel MM, Burhenne J, Walter-Sack I, Hoffmann MM, Rengelshausen J, Haefeli WE, Mikus G</div><div class="citation">J Clin Pharmacol. 2009 Feb; 49(2):196-204.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/19033450/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B30">Ref list</a>]</p></div><div id="body-link-popper-B11" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> The enzymatic basis of drug-drug interactions with systemic triazole antifungals.<div class="authors">Nivoix Y, Levêque D, Herbrecht R, Koffel JC, Beretz L, Ubeaud-Sequier G</div><div class="citation">Clin Pharmacokinet. 2008; 47(12):779-92.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/19026034/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B11">Ref list</a>]</p></div><div id="body-link-popper-B25" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Pharmacokinetic/pharmacodynamic profile of voriconazole.<div class="authors">Theuretzbacher U, Ihle F, Derendorf H</div><div class="citation">Clin Pharmacokinet. 2006; 45(7):649-63.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16802848/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B25">Ref list</a>]</p></div><div id="body-link-popper-B12" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes.<div class="authors">Niwa T, Shiraga T, Takagi A</div><div class="citation">Biol Pharm Bull. 2005 Sep; 28(9):1805-8.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16141567/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B12">Ref list</a>]</p></div><div id="body-link-popper-B23" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Combination antifungals: an update.<div class="authors">Segal BH, Steinbach WJ</div><div class="citation">Expert Rev Anti Infect Ther. 2007 Oct; 5(5):883-92.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17914921/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B23">Ref list</a>]</p></div><div id="body-link-popper-B18" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">18. <span class="mixed-citation">
Prentice A. G., et al.  2008.  <span class="ref-title">Guidelines on the management of invasive fungal infection during therapy for haematological malignancy. BCSH guidelines home page</span>. Pfizer Inc., New York, NY</span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B18">Ref list</a>]</div><div id="body-link-popper-B26" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Recommendations for the treatment of established fungal infections.<div class="authors">Thursky KA, Playford EG, Seymour JF, Sorrell TC, Ellis DH, Guy SD, Gilroy N, Chu J, Shaw DR</div><div class="citation">Intern Med J. 2008 Jun; 38(6b):496-520.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18588522/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B26">Ref list</a>]</p></div><div id="body-link-popper-B28" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.<div class="authors">Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF, Infectious Diseases Society of America</div><div class="citation">Clin Infect Dis. 2008 Feb 1; 46(3):327-60.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18177225/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B28">Ref list</a>]</p></div><div id="body-link-popper-B14" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Voriconazole in the management of nosocomial invasive fungal infections.<div class="authors">Pemán J, Salavert M, Cantón E, Jarque I, Romá E, Zaragoza R, Viudes A, Gobernado M</div><div class="citation">Ther Clin Risk Manag. 2006 Jun; 2(2):129-58.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18360588/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B14">Ref list</a>]</p></div><div id="body-link-popper-B15" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.<div class="authors">Pfaller MA, Messer SA, Hollis RJ, Jones RN, Diekema DJ</div><div class="citation">Antimicrob Agents Chemother. 2002 Jun; 46(6):1723-7.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/12019081/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B15">Ref list</a>]</p></div><div id="body-link-popper-B21" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection.<div class="authors">Ruhnke M, Schmidt-Westhausen A, Trautmann M</div><div class="citation">Antimicrob Agents Chemother. 1997 Mar; 41(3):575-7.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9055995/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B21">Ref list</a>]</p></div><div id="body-link-popper-B2" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">2. <span class="mixed-citation">
European Medicines Agency 2009.  <span class="ref-title">Vfend: EPAR–product information (last updated January 2011)</span>. European Medicines Agency, London, United Kingdom:  <a href="http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000387/human_med_001135.jsp&amp;murl=menus/medicines/medicines.jsp&amp;mid=WC0b01ac058001d125" ref="reftype=extlink&amp;article-id=3195022&amp;issue-id=201205&amp;journal-id=82&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="pmc_ext">http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000387/human_med_001135.jsp&amp;murl=menus/medicines/medicines.jsp&amp;mid=WC0b01ac058001d125</a> Accessed 11 March 2011</span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B2">Ref list</a>]</div><div id="body-link-popper-B27" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.<div class="authors">Venkatakrishnan K, von Moltke LL, Greenblatt DJ</div><div class="citation">Clin Pharmacokinet. 2000 Feb; 38(2):111-80.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/10709776/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B27">Ref list</a>]</p></div><div id="body-link-popper-B16" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">16. <span class="mixed-citation">
Pfizer Inc 2010.  <span class="ref-title">Diflucan—U.S. prescribing information (revised January 2010)</span>. Pfizer Inc., New York, NY</span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B16">Ref list</a>]</div><div id="body-link-popper-B33" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele.<div class="authors">Xiao ZS, Goldstein JA, Xie HG, Blaisdell J, Wang W, Jiang CH, Yan FX, He N, Huang SL, Xu ZH, Zhou HH</div><div class="citation">J Pharmacol Exp Ther. 1997 Apr; 281(1):604-9.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9103550/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B33">Ref list</a>]</p></div><div id="body-link-popper-B1" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Pharmacokinetics and tolerability of voriconazole and a combination oral contraceptive co-administered in healthy female subjects.<div class="authors">Andrews E, Damle BD, Fang A, Foster G, Crownover P, LaBadie R, Glue P</div><div class="citation">Br J Clin Pharmacol. 2008 Apr; 65(4):531-9.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18294327/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B1">Ref list</a>]</p></div><div id="body-link-popper-B9" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Roles of CYP3A4 and CYP2C19 in methyl hydroxylated and N-oxidized metabolite formation from voriconazole, a new anti-fungal agent, in human liver microsomes.<div class="authors">Murayama N, Imai N, Nakane T, Shimizu M, Yamazaki H</div><div class="citation">Biochem Pharmacol. 2007 Jun 15; 73(12):2020-6.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17433262/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B9">Ref list</a>]</p></div><div id="body-link-popper-B31" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19.<div class="authors">Wienkers LC, Wurden CJ, Storch E, Kunze KL, Rettie AE, Trager WF</div><div class="citation">Drug Metab Dispos. 1996 May; 24(5):610-4.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/8723744/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B31">Ref list</a>]</p></div><div id="body-link-popper-B4" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Metabolism of rifabutin in human enterocyte and liver microsomes: kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents.<div class="authors">Iatsimirskaia E, Tulebaev S, Storozhuk E, Utkin I, Smith D, Gerber N, Koudriakova T</div><div class="citation">Clin Pharmacol Ther. 1997 May; 61(5):554-62.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9164417/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B4">Ref list</a>]</p></div><div id="body-link-popper-B8" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture.<div class="authors">Maurice M, Pichard L, Daujat M, Fabre I, Joyeux H, Domergue J, Maurel P</div><div class="citation">FASEB J. 1992 Jan 6; 6(2):752-8.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/1371482/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B8">Ref list</a>]</p></div><div id="body-link-popper-B10" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">In vitro metabolism of quinidine: the (3S)-3-hydroxylation of quinidine is a specific marker reaction for cytochrome P-4503A4 activity in human liver microsomes.<div class="authors">Nielsen TL, Rasmussen BB, Flinois JP, Beaune P, Brosen K</div><div class="citation">J Pharmacol Exp Ther. 1999 Apr; 289(1):31-7.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/10086984/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B10">Ref list</a>]</p></div><div id="body-link-popper-B34" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Potential impact of cytochrome P450 3A5 in human liver on drug interactions with triazoles.<div class="authors">Yamazaki H, Nakamoto M, Shimizu M, Murayama N, Niwa T</div><div class="citation">Br J Clin Pharmacol. 2010 Jun; 69(6):593-7.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/20565450/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B34">Ref list</a>]</p></div><div id="body-link-popper-B6" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms.<div class="authors">Ko JW, Sukhova N, Thacker D, Chen P, Flockhart DA</div><div class="citation">Drug Metab Dispos. 1997 Jul; 25(7):853-62.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/9224780/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B6">Ref list</a>]</p></div><div id="body-link-popper-B32" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Effect of omeprazole on the steady-state pharmacokinetics of voriconazole.<div class="authors">Wood N, Tan K, Purkins L, Layton G, Hamlin J, Kleinermans D, Nichols D</div><div class="citation">Br J Clin Pharmacol. 2003 Dec; 56 Suppl 1():56-61.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/14616415/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B32">Ref list</a>]</p></div><div id="body-link-popper-B17" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">17. <span class="mixed-citation">
Pfizer Inc 2010.  <span class="ref-title">Vfend—U.S. prescribing information (revised June 2010)</span>. Pfizer Inc., New York, NY</span> [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B17">Ref list</a>]</div><div id="body-link-popper-B24" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Investigation of the potential relationships between plasma voriconazole concentrations and visual adverse events or liver function test abnormalities.<div class="authors">Tan K, Brayshaw N, Tomaszewski K, Troke P, Wood N</div><div class="citation">J Clin Pharmacol. 2006 Feb; 46(2):235-43.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/16432276/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B24">Ref list</a>]</p></div><div id="body-link-popper-B5" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Neurological adverse events to voriconazole: evidence for therapeutic drug monitoring.<div class="authors">Imhof A, Schaer DJ, Schanz U, Schwarz U</div><div class="citation">Swiss Med Wkly. 2006 Nov 11; 136(45-46):739-42.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/17183438/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B5">Ref list</a>]</p></div><div id="body-link-popper-B13" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.<div class="authors">Pascual A, Calandra T, Bolay S, Buclin T, Bille J, Marchetti O</div><div class="citation">Clin Infect Dis. 2008 Jan 15; 46(2):201-11.</div><p>[<a href="http://www.ncbi.nlm.nih.gov/pubmed/18171251/">PubMed</a>] [<a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#B13">Ref list</a>]</p></div></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <div class="breadcrumbs">You are here: 
            <span id="breadcrumb_text"><a href="http://www.ncbi.nlm.nih.gov/guide/">NCBI</a> &gt; <a href="http://www.ncbi.nlm.nih.gov/guide/literature/">Literature</a> &gt; <a href="http://www.ncbi.nlm.nih.gov/pmc/">PubMed Central (PMC)</a></span></div>
    <a id="help-desk-link" class="help_desk jig-ncbihelpwindow" target="_blank" href="http://www.ncbi.nlm.nih.gov/sites/ehelp?&amp;Ncbi_App=pmc&amp;Db=pmc&amp;Page=literature&amp;Snapshot=/projects/PMC/PMCViewer@4.35&amp;Time=2016-06-23T14:31:10-04:00&amp;Host=ptpmc101">Write to the Help Desk</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="./PMC3195022_files/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="http://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="http://www.nlm.nih.gov/" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="http://www.nih.gov/" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="http://www.dhhs.gov/" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="http://www.usa.gov/" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            
            <a href="http://www.ncbi.nlm.nih.gov/About/disclaimer.html">Copyright</a> | <a href="http://www.ncbi.nlm.nih.gov/About/disclaimer.html#disclaimer">Disclaimer</a> |
            <a href="http://www.nlm.nih.gov/privacy.html" class="newdomain">Privacy</a> | 
            <a href="http://www.ncbi.nlm.nih.gov/guide/browsers/">Browsers</a> | <a href="http://www.nlm.nih.gov/accessibility.html">Accessibility</a> | <a href="http://www.ncbi.nlm.nih.gov/About/glance/contact_info.html">Contact</a>
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="http://www.ncbi.nlm.nih.gov/">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url"><a href="http://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
        </div>
    </div>
    <script type="text/javascript" src="./PMC3195022_files/InstrumentPageStarterJS.js"> </script>    
    <script type="text/javascript" src="./PMC3195022_files/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="http://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div><div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 63.5938px; left: 408.188px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: none;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195022/#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: none;">Turn off</a></div></div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript>&lt;img alt="statistics" src="/stat?jsdisabled=true&amp;amp;ncbi_db=pmc&amp;amp;ncbi_pdid=article&amp;amp;ncbi_acc=&amp;amp;ncbi_domain=aac&amp;amp;ncbi_report=record&amp;amp;ncbi_type=fulltext&amp;amp;ncbi_objectid=&amp;amp;ncbi_pcid=/articles/PMC3195022/&amp;amp;ncbi_app=pmc" /&gt;</noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- F4FC7E8376854741_0014SID /projects/PMC/PMCViewer@4.35 ptpmc101 v4.1.r480124 Mon, Sep 28 2015 02:46:19 -->

<script type="text/javascript" src="./PMC3195022_files/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1" style="display: none;"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div><ul class="print-log"><li></li></ul></body></html>